https://curecurrent.com/trials/prognostic-evaluation-of-covid-19-in-rheumatoid-arthritis-patients-102006https://curecurrent.com/trials/preventive-approach-to-congenital-heart-block-with-hydroxychloroquine-102007https://curecurrent.com/trials/evaluation-of-a-non-face-to-face-multidisciplinary-health-care-model-in-a-population-with-rheumatoid-arthritis-102008https://curecurrent.com/trials/comparison-of-two-etanercept-regimens-reumatocept-versus-enbrel-for-treatment-of-rheumatoid-arthritis-102009https://curecurrent.com/trials/effect-of-subcutaneous-actemra-on-inflamed-atherosclerotic-plaques-in-patients-with-rheumatoid-arthritis-102010https://curecurrent.com/trials/effectiveness-of-kinesio-tape-in-morning-stiffness-and-functional-capacity-in-patients-with-rheumatoid-arthritis-102011https://curecurrent.com/trials/power-doppler-in-hand-joints-of-early-ra-patients-102012https://curecurrent.com/trials/a-study-to-evaluate-the-rna-signature-of-rheumatoid-arthritis-from-synovium-and-whole-blood-102013https://curecurrent.com/trials/progress-at-work-the-impact-of-adalimumab-on-work-related-productivity-in-patients-with-rheumatoid-arthritis-102014https://curecurrent.com/trials/evaluation-of-adult-onset-still-disease-classification-criteria-and-differential-diagnosis-at-eighteen-months-of-follow-102015https://curecurrent.com/trials/study-of-leukocyte-populations-in-patients-with-chronic-inflammatory-102016https://curecurrent.com/trials/exercise-and-mediterranean-diet-on-body-composition-disease-activity-and-inflammatory-markers-in-rheumatoid-arthritis-102017https://curecurrent.com/trials/study-to-assess-the-safety-and-tolerability-of-medi5117-in-rheumatoid-arthritis-patients-102018https://curecurrent.com/trials/start-time-optimization-of-biologics-in-polyarticular-jia-102019https://curecurrent.com/trials/observational-study-to-evaluate-the-real-life-effectiveness-of-benepali-following-transition-from-enbrel-102020https://curecurrent.com/trials/objective-measurement-methods-for-autoimmune-disease-and-dry-eye-syndrome-102021https://curecurrent.com/trials/comparative-efficacy-safety-and-immunogenicity-study-of-etanercept-and-enbrel-102022https://curecurrent.com/trials/multi-center-registration-study-of-adult-onset-still-s-disease-in-chinese-population-102023https://curecurrent.com/trials/a-pilot-open-label-crossover-bioavailability-study-of-celecoxib-in-healthy-volunteers-102024https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-celecoxib-celebrex-or-naproxen-on-blood-pressure-in-pediatric-subjects-102025https://curecurrent.com/trials/study-to-demonstrate-non-inferior-efficacy-and-safety-of-cinnora-versus-humira-for-treatment-of-active-ra-102026https://curecurrent.com/trials/evaluation-of-the-mechanisms-of-sarcopenia-in-chronic-inflammatory-disease-protocol-for-a-prospective-cohort-study-102027https://curecurrent.com/trials/naturalistic-safety-registry-of-celecoxib-celebrex-r-and-nsaids-in-juvenile-idiopathic-arthritis-102028https://curecurrent.com/trials/toward-the-lowest-effective-dose-of-abatacept-or-tocilizumab-102029https://curecurrent.com/trials/the-relation-between-macrophage-migration-inhibitory-factor-mif-and-25-oh-vitamin-d3-serum-levels-in-rheumatoid-arthriti-102030https://curecurrent.com/trials/characterizing-rheumatoid-arthritis-with-68ga-fapi-pet-ct-102031https://curecurrent.com/trials/optimization-of-infliximab-withdrawal-strategy-for-rheumatoid-arthritis-102032https://curecurrent.com/trials/effect-of-baricitinib-treatment-on-peripheral-bone-in-ra-102033https://curecurrent.com/trials/study-to-evaluate-the-pharmacokinetics-of-filgotinib-in-participants-with-impaired-hepatic-function-102034https://curecurrent.com/trials/acthar-for-acute-treatment-of-rheumatoid-arthritis-patients-with-inadequate-response-to-methotrexate-102035https://curecurrent.com/trials/progression-of-bone-erosions-in-rheumatoid-arthritis-assessed-by-hr-pqct-and-conventional-x-ray-102036https://curecurrent.com/trials/a-study-of-the-pharmacokinetics-and-safety-of-sm03-in-patients-with-rheumatoid-arthritis-102037https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-gsk3196165-plus-methotrexate-in-subjects-with-active-moderate-severe-rheuma-102038https://curecurrent.com/trials/mechanistic-study-of-gsk3196165-plus-methotrexate-mtx-in-subjects-with-active-rheumatoid-arthritis-102039https://curecurrent.com/trials/a-study-assessing-the-efficacy-and-safety-of-sm03-in-patients-with-active-rheumatoid-arthritis-receiving-mtx-102040https://curecurrent.com/trials/a-study-to-evaluate-the-pharmacokinetics-of-abatacept-converted-from-drug-substance-by-two-different-processes-102041https://curecurrent.com/trials/association-between-long-term-hydroxychloroquine-treatment-and-outcome-of-a-history-of-symptoms-suggestive-of-covid-19-i-102042https://curecurrent.com/trials/effect-of-laser-puncture-on-rheumatoid-arthritis-patients-102043https://curecurrent.com/trials/safety-pharmacokinetics-and-preliminary-efficacy-study-of-cfz533-in-patients-with-primary-sj-gren-s-syndrome-102044https://curecurrent.com/trials/covid-serology-in-rheumatoid-arthritis-covid-19-102045https://curecurrent.com/trials/nerve-block-of-the-proximal-interphalangeal-joints-pips-in-rheumatoid-arthritis-ra-patients-a-prospective-pilot-study-102046https://curecurrent.com/trials/noninterventional-examination-of-subcutaneous-sc-tumor-necrosis-factor-tnf-inhibitors-102047https://curecurrent.com/trials/prevalence-and-seroconversion-of-covid-19-in-autoimmune-diseases-in-europe-102048https://curecurrent.com/trials/real-life-experience-of-tofacitinib-in-patients-with-treatment-resistant-rheumatoid-arthritis-102049https://curecurrent.com/trials/cf101-therapy-compared-to-methotrexate-therapy-for-active-rheumatoid-arthritis-102050https://curecurrent.com/trials/pmcf-study-of-the-cls-brevius-stem-with-kinectiv-technology-102051https://curecurrent.com/trials/jak2-mutation-may-predict-response-and-guide-first-line-treatment-in-rheumatoid-arthritis-102052https://curecurrent.com/trials/dose-finding-study-of-glpg0634-as-monotherapy-in-active-rheumatoid-arthritis-ra-participants-darwin2-102053https://curecurrent.com/trials/study-in-patients-with-moderated-to-severe-rheumatoid-arthritis-who-have-failed-to-combination-therapy-of-conventional-d-102054https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-single-dose-cfz533-in-rheumatoid-arthritis-patients-102055https://curecurrent.com/trials/psychological-impact-of-quarantine-in-rheumatoid-arthritis-patient-during-covid-19-outbreak-102056https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-study-of-vay736-in-rheumatoid-arthritis-patients-102057https://curecurrent.com/trials/stepping-up-for-inflammatory-arthritis-102058https://curecurrent.com/trials/a-study-to-evaluate-ocrelizumab-compared-with-placebo-in-patients-with-rheumatoid-arthritis-who-have-an-inadequate-respo-102059https://curecurrent.com/trials/a-study-to-assess-efficacy-and-safety-of-wangbi-capsule-in-patients-with-rheumatoid-arthritis-102060https://curecurrent.com/trials/first-time-in-human-ftih-study-to-evaluate-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-single-in-both-f-102061https://curecurrent.com/trials/a-study-of-liquid-certolizumab-pegol-as-additional-medication-to-methotrexate-in-the-treatment-of-signs-and-symptoms-of-102062https://curecurrent.com/trials/ultrasound-and-withdrawal-of-biological-dmards-in-rheumatoid-arthritis-102063https://curecurrent.com/trials/a-study-of-arry-438162-in-patients-with-rheumatoid-arthritis-102064https://curecurrent.com/trials/a-placebo-controlled-study-to-assess-efficacy-and-safety-of-certolizumab-pegol-in-the-treatment-of-rheumatoid-arthritis-102065https://curecurrent.com/trials/a-study-of-ocrelizumab-compared-to-placebo-in-patients-with-active-rheumatoid-arthritis-continuing-methotrexate-treatmen-102066https://curecurrent.com/trials/rhythm-formerly-escape-ii-myocardium-102067https://curecurrent.com/trials/effect-of-denosumab-in-erosion-healing-in-ra-102068https://curecurrent.com/trials/phase-2a-clinical-trial-of-hl237-for-rheumatoid-arthritis-102069https://curecurrent.com/trials/dose-finding-study-of-glpg0634-as-add-on-to-methotrexate-in-active-rheumatoid-arthritis-participants-darwin1-102070https://curecurrent.com/trials/long-term-observation-of-patients-with-early-rheumatoid-arthritis-102071https://curecurrent.com/trials/abatacept-vs-placebo-in-ra-patients-with-hepatitis-b-on-entecavir-background-102072https://curecurrent.com/trials/chronic-inflammatory-disease-lifestyle-and-risk-of-disease-102073https://curecurrent.com/trials/a-study-to-evaluate-ocrelizumab-in-combination-with-methotrexate-compared-with-infliximab-plus-methotrexate-in-patients-102074https://curecurrent.com/trials/a-comparison-of-two-electronic-gloves-in-the-measurement-of-joint-movement-in-patients-with-rheumatoid-arthritis-102075https://curecurrent.com/trials/a-study-of-ocrelizumab-in-combination-with-methotrexate-in-patients-with-rheumatoid-arthritis-who-are-naive-to-methotrex-102076https://curecurrent.com/trials/efficacy-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-gsk3117391-in-subjects-with-rheumatoid-arthritis-102077https://curecurrent.com/trials/the-clinical-feasibilityof-a-multi-modal-photoacoustic-ultrasonic-imaging-system-in-rheumatoid-arthritis-102078https://curecurrent.com/trials/measuring-the-impact-of-an-innovative-educational-intervention-in-inflammatory-arthritis-102079https://curecurrent.com/trials/a-musculoskeletal-ultrasound-program-to-improve-disease-modifying-anti-rheumatic-drugs-adherence-in-rheumatoid-arthritis-102080https://curecurrent.com/trials/early-biomarkers-for-arthritic-pain-to-guide-improved-treatments-for-arthritis-102081https://curecurrent.com/trials/study-to-assess-safety-and-efficacy-of-filgotinib-lanraplenib-and-tirabrutinib-in-adults-with-active-sjogren-s-syndrome-102082https://curecurrent.com/trials/pain-modulation-in-rheumatoid-arthritis-ra-influence-of-adalimumab-102083https://curecurrent.com/trials/telehealth-follow-up-in-patients-with-rheumatoid-arthritis-102084https://curecurrent.com/trials/patient-reported-outcomes-in-rheumatoid-arthritis-patients-treated-with-tofacitinib-or-biological-disease-modifying-anti-102085https://curecurrent.com/trials/assessment-of-treatment-safety-and-quality-of-life-in-patients-receiving-etanercept-biosimilar-for-autoimmune-arthritis-102086https://curecurrent.com/trials/a-study-of-iguratimod-in-patients-with-active-rheumatoid-arthritis-102087https://curecurrent.com/trials/99mtc-rhannexin-v-128-a-phase-i-iia-study-in-patients-with-rheumatoid-arthritis-ra-or-ankylosing-spondylitis-as-102088https://curecurrent.com/trials/study-to-assess-if-abp-798-is-safe-effective-in-treating-moderate-to-severe-rheumatoid-arthritis-ra-compared-to-rituxima-102089https://curecurrent.com/trials/freedom-total-knee-system-for-treatment-of-osteoarthritis-rheumatoid-arthritis-or-post-traumatic-arthritis-102090https://curecurrent.com/trials/early-phase-study-to-assess-efficacy-and-safety-of-azd9567-versus-prednisolone-in-patients-with-rheumatoid-arthritis-102091https://curecurrent.com/trials/treatment-of-pregnancy-ra-102092https://curecurrent.com/trials/mechanistic-studies-of-b-and-t-cell-function-in-ra-patients-treated-with-tnf-antagonists-tocilizumab-or-abatacept-102093https://curecurrent.com/trials/does-adding-an-additional-numbing-medication-injection-in-the-thigh-help-with-pain-control-after-knee-replacement-surger-102094https://curecurrent.com/trials/study-evaluating-erb-041-with-methotrexate-in-rheumatoid-arthritis-102095https://curecurrent.com/trials/italian-registry-of-arthritis-on-biologic-therapy-102096https://curecurrent.com/trials/phase-iib-study-of-evobrutinib-in-subjects-with-rheumatoid-arthritis-102097https://curecurrent.com/trials/relationship-between-grip-endurance-disability-of-upper-extremity-and-quality-of-life-in-patients-with-ra-102098https://curecurrent.com/trials/study-of-tocilizumab-roactemre-administered-subcutaneously-in-participants-with-rheumatoid-arthritis-in-everyday-clinica-102099https://curecurrent.com/trials/serologic-profile-of-sars-cov2-in-covid-19-patients-with-systemic-diseases-102100https://curecurrent.com/trials/a-study-of-arry-371797-in-patients-with-rheumatoid-arthritis-102101https://curecurrent.com/trials/neuropathic-foot-and-ankle-in-rheumatoid-arthritis-ultrasound-and-nerve-conduction-study-102102https://curecurrent.com/trials/a-retrospective-cohort-study-on-the-risk-of-serious-infections-in-rheumatoid-arthritis-patients-receiving-tocilizumab-102103https://curecurrent.com/trials/hydroxy-chloroquine-and-covid-in-ra-patients-102104https://curecurrent.com/trials/incorporation-of-patient-reported-outcomes-data-in-the-care-of-us-veterans-with-rheumatoid-arthritis-102105https://curecurrent.com/trials/myslainte-testing-the-effect-of-involving-partners-in-a-cvd-prevention-community-lifestyle-program-102106https://curecurrent.com/trials/assessment-of-leflunomide-efficacy-and-hepatotoxicity-in-patients-with-rheumatoid-arthritis-through-pharmacokinetic-and-102107https://curecurrent.com/trials/study-to-evaluate-safety-and-pharmacokinetics-of-gs-4059-tirabrutinib-in-healthy-volunteers-and-participants-with-rheuma-102108https://curecurrent.com/trials/stratification-of-oral-ulcers-in-rheumatoid-arthritis-patients-kept-on-methotrexate-102109https://curecurrent.com/trials/near-infrared-fluorescence-using-indocyanine-green-and-magnetic-resonance-lymphography-of-lymphatic-transport-102110https://curecurrent.com/trials/optimizing-the-management-of-flares-in-patients-with-rheumatoid-arthritis-ra-102111https://curecurrent.com/trials/fluorine-f-18-clofarabine-pet-ct-in-imaging-patients-with-autoimmune-or-inflammatory-diseases-102112https://curecurrent.com/trials/study-to-assess-changes-in-the-immune-profile-in-adults-with-early-rheumatoid-arthritis-102113https://curecurrent.com/trials/role-of-l-arginine-supplementation-in-the-treatment-of-rheumatoid-arthritis-102114https://curecurrent.com/trials/cell-surface-marker-expression-in-autoimmune-diseases-102115https://curecurrent.com/trials/blood-component-collection-from-patients-with-rheumatic-or-kidney-disease-and-healthy-volunteers-102116https://curecurrent.com/trials/study-of-hip-and-knee-arthroplasty-in-south-africa-102117https://curecurrent.com/trials/efficacy-and-safety-study-of-tas5315-compared-with-placebo-in-participants-with-rheumatoid-arthritis-102118https://curecurrent.com/trials/a-study-of-e6011-in-japanese-subjects-with-rheumatoid-arthritis-102119https://curecurrent.com/trials/effectiveness-of-bazedoxifene-for-prevention-of-glucocorticoid-induced-bone-loss-in-ra-patients-102120https://curecurrent.com/trials/measurement-of-the-structural-efficacy-in-active-ra-patients-treated-with-sarilumab-in-combination-with-mtx-and-naive-to-102121https://curecurrent.com/trials/anti-il6r-reduce-complement-serum-level-in-rheumatoid-arthritis-patients-facts-and-implications-102122https://curecurrent.com/trials/a-study-on-the-use-of-tourniquet-use-in-primary-total-knee-arthroplasty-102123https://curecurrent.com/trials/effect-of-pharmaceutical-consultations-just-before-rheumatology-consultations-on-improving-knowledge-and-skills-for-pati-102124https://curecurrent.com/trials/bay1830839-first-in-man-single-dose-escalation-safety-tolerability-and-pharmacokinetics-102125https://curecurrent.com/trials/clinical-performance-of-bioclia-ro60-102126https://curecurrent.com/trials/a-study-to-evaluate-the-long-term-safety-and-efficacy-of-gdc-0853-in-participants-with-moderate-to-severe-rheumatoid-art-102127https://curecurrent.com/trials/association-between-methotrexate-erythrocyte-polyglutamate-concentration-and-clinical-response-in-rheumatoid-arthritis-p-102128https://curecurrent.com/trials/vaccination-in-methotrexate-treated-rheumatoid-arthritis-patients-102129https://curecurrent.com/trials/liver-fibrosis-and-gut-microbiota-in-patients-with-psoriasis-vulgaris-and-rheumatoid-arthritis-on-methotrexate-102130https://curecurrent.com/trials/the-effectiveness-of-3rd-occipital-radiofrequency-versus-systemic-steroid-in-headache-management-in-rheumatoid-arthritis-102131https://curecurrent.com/trials/can-cytokines-be-used-as-an-activation-marker-102132https://curecurrent.com/trials/bone-microarchitecture-abatacept-bma2-102133https://curecurrent.com/trials/relationship-of-periodontitis-and-cardiovascular-risk-in-patients-with-rheumatoid-arthritis-102134https://curecurrent.com/trials/study-of-human-placenta-derived-cells-pda001-to-evaluate-the-safety-and-effectiveness-for-patients-with-active-rheumatoi-102135https://curecurrent.com/trials/evaluate-the-safety-tolerability-pharmacokinetics-and-clinical-activity-of-fb704a-102136https://curecurrent.com/trials/regulatory-b-cells-in-inflammatory-rheumatisms-and-biomarkers-of-response-to-biologic-treatments-102137https://curecurrent.com/trials/outpatient-follow-up-on-demand-in-rheumatoid-arthritis-102138https://curecurrent.com/trials/national-data-bank-for-rheumatic-disease-registry-study-of-safety-in-patients-with-rheumatoid-arthritis-treated-with-cim-102139https://curecurrent.com/trials/study-of-tapering-and-discontinuing-biological-dmards-in-rheumatoid-arthritis-patients-102140https://curecurrent.com/trials/vitamin-d-effect-in-rheumatoid-arthritis-102141https://curecurrent.com/trials/safety-efficacy-and-pharmacokinetics-study-of-ald518-in-patients-with-active-rheumatoid-arthritis-102142https://curecurrent.com/trials/can-musculoskeletal-ultrasound-predict-fall-risk-in-rheumatoid-arthritis-patients-102143https://curecurrent.com/trials/tofacitinib-versus-methotrexate-as-the-first-line-dmard-in-the-treatment-of-rheumatoid-arthritis-102144https://curecurrent.com/trials/glucocorticoid-induced-tumour-necrosis-factor-receptor-related-protein-gitr-in-rheumatoid-arthritis-102145https://curecurrent.com/trials/clinical-efficacy-and-safety-of-leflunomide-in-egyptian-patients-with-active-rheumatoid-arthritis-102146https://curecurrent.com/trials/post-market-clinical-follow-up-of-the-zimmer-stafit-acetabular-system-102147https://curecurrent.com/trials/comparative-effectiveness-of-targeted-therapy-in-ra-patients-102148https://curecurrent.com/trials/a-multi-center-study-a-single-iv-infusion-of-allogeneic-mpcs-in-patients-with-rheumatoid-arthritis-and-incomplete-respon-102149https://curecurrent.com/trials/effectiveness-and-safety-of-tofacitinib-in-korean-patients-with-rheumatoid-arthritis-102150https://curecurrent.com/trials/impact-of-behavioral-factors-on-treatment-adherence-in-a-sample-of-rheumatoid-arthritis-patients-102151https://curecurrent.com/trials/combination-therapy-prevents-the-relapse-of-ra-102152https://curecurrent.com/trials/the-effects-of-exercise-on-some-biochemical-parameters-in-patients-with-rheumatoid-arthritis-102153https://curecurrent.com/trials/effects-of-acute-exercise-on-bdnf-levels-in-rheumatoid-arthritis-patients-102154https://curecurrent.com/trials/microbial-dysbiosis-in-rheumatoid-arthritis-102155https://curecurrent.com/trials/treatment-outcome-and-prognostic-factors-for-rheumatoid-arthritis-ra-patients-with-interstitial-lung-disease-ild-102156https://curecurrent.com/trials/safety-and-efficacy-study-of-gdc-0853-compared-with-placebo-and-adalimumab-in-participants-with-rheumatoid-arthritis-ra-102157https://curecurrent.com/trials/impact-of-barriers-and-facilitators-to-physical-activity-in-patients-with-inflammatory-arthritis-102158https://curecurrent.com/trials/research-study-on-the-immunosuppressive-effects-of-a-cell-therapy-product-on-pbmc-isolated-from-blood-of-patients-with-i-102159https://curecurrent.com/trials/the-effects-of-social-role-participation-on-life-quality-102160https://curecurrent.com/trials/impact-of-korean-red-ginseng-on-fatigue-in-patients-with-rheumatic-disease-102161https://curecurrent.com/trials/14-3-3-protein-disease-activity-and-bone-mineral-density-in-female-patients-with-rheumatoid-arthritis-102162https://curecurrent.com/trials/the-anti-inflammatory-effects-of-hark-ny-medicinal-water-102163https://curecurrent.com/trials/fecal-microbial-transplant-fmt-for-sjogrens-syndrome-102164https://curecurrent.com/trials/the-treat-to-target-study-of-ra-based-on-smart-system-of-disease-management-ssdm-102165https://curecurrent.com/trials/performance-of-ct-parameters-compared-to-bone-mineral-density-to-detect-bone-fragility-in-rheumatoid-arthritis-102166https://curecurrent.com/trials/cthrc1-a-biomarker-for-evaluation-of-rheumatoid-arthritis-disease-activity-102167https://curecurrent.com/trials/rheumatoid-arthritis-hematological-indices-102168https://curecurrent.com/trials/comparative-effectiveness-and-safety-of-biosimilar-and-legacy-drugs-102169https://curecurrent.com/trials/role-of-cthrc1-in-diagnosis-of-rheumatoid-arthritis-102170https://curecurrent.com/trials/cyclosporine-a-in-the-treatment-of-interstitial-pneumonitis-associated-with-sjogren-s-syndrome-102171https://curecurrent.com/trials/a-study-to-evaluate-the-use-of-glucocorticoids-in-combination-with-tocilizumab-in-daily-clinical-practice-102172https://curecurrent.com/trials/re-evaluation-of-some-old-rheumatoid-arthritis-therapy-a-randomized-controlled-trial-102173https://curecurrent.com/trials/antimalarial-and-covid-19-in-rheumatoid-arthritis-102174https://curecurrent.com/trials/mabioncd20-compared-to-mabthera-in-patients-with-rheumatoid-arthritis-102175https://curecurrent.com/trials/yoga-for-patients-with-rheumatoid-arthritis-102176https://curecurrent.com/trials/the-safety-and-effectiveness-of-tocilizumab-in-rheumatoid-arthritis-102177https://curecurrent.com/trials/tdcs-for-fatigue-in-sjogren-s-syndrome-102178https://curecurrent.com/trials/study-of-apremilast-to-evaluate-the-safety-and-effectiveness-for-patients-with-rheumatoid-arthritis-102179https://curecurrent.com/trials/effectiveness-of-technology-supported-hand-strengthening-and-stretching-exercises-in-patients-with-rheumatoid-arthritis-102180https://curecurrent.com/trials/effect-of-sarilumab-on-atherosclerotic-disease-assessed-by-pet-cet-in-patients-with-ra-saripet-102181https://curecurrent.com/trials/cxcl10-as-a-biomarker-of-ild-in-patients-withra-102182https://curecurrent.com/trials/kickstart30-a-30-day-intervention-for-patients-with-rheumatoid-arthritis-ra-102183https://curecurrent.com/trials/comparative-and-pragmatic-study-of-golimumab-intravenous-iv-simponi-aria-versus-infliximab-remicade-in-rheumatoid-arthri-102184https://curecurrent.com/trials/comparison-of-the-effectiveness-of-two-different-dosages-of-cortisone-compared-to-placebo-in-rheumatoid-arthritis-102185https://curecurrent.com/trials/a-phase-i-iii-study-to-evaluate-efficacy-pk-and-safety-between-ct-p13-sc-and-ct-p13-iv-in-patients-with-active-ra-102186https://curecurrent.com/trials/effects-of-interleukin-6-inhibition-on-vascular-endothelial-and-left-ventricular-function-in-rheumatoid-arthritis-102187https://curecurrent.com/trials/safety-and-effectiveness-of-acthar-gel-in-participants-with-rheumatoid-arthritis-102188https://curecurrent.com/trials/evaluation-of-pharmacist-s-intervention-in-improving-treatment-outcomes-of-rheumatoid-arthritis-a-randomized-controlled-102189https://curecurrent.com/trials/a-clinical-investigation-of-arcomxl-polyethylene-in-total-hip-replacement-102190https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-liquid-certolizumab-pegol-in-the-treatment-of-signs-and-symptoms-of-rheumatoi-102191https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-lyophilized-certolizumab-pegol-in-the-treatment-of-signs-and-symptoms-of-rheu-102192https://curecurrent.com/trials/comparison-of-pk-and-tolerability-of-msb11022-administered-by-ai-or-pfs-102193https://curecurrent.com/trials/promoting-engagement-in-physical-activity-in-early-rheumatoid-arthritis-proof-of-concept-study-102194https://curecurrent.com/trials/evaluation-of-rheumatoid-arthritis-disease-education-literature-102195https://curecurrent.com/trials/interaction-between-immune-cells-and-bacteria-associated-with-periodontitis-102196https://curecurrent.com/trials/the-effects-of-hyperbaric-oxygen-on-rheumatoid-arthritis-102197https://curecurrent.com/trials/impact-of-pharmacist-intervention-on-disease-knowledge-rehabilitation-and-medication-adherence-treatment-induced-direct-102198https://curecurrent.com/trials/the-effect-of-bms-986195-combined-with-an-oral-contraceptive-ethinyl-estradiol-norethindrone-in-healthy-female-patients-102199https://curecurrent.com/trials/cmab008-with-mtx-therapy-in-adult-patients-with-moderately-to-severely-active-rheumatoid-arthritis-102200https://curecurrent.com/trials/transplantation-of-autologous-bone-marrow-derived-stem-cells-in-patients-with-rheumatoid-arthritis-102201https://curecurrent.com/trials/identification-of-genes-involved-in-juvenile-idiopathic-arthritis-by-wholel-exome-sequencing-102202https://curecurrent.com/trials/prediction-of-response-to-certolizumab-pegol-treatment-by-functional-mri-of-the-brain-102203https://curecurrent.com/trials/safety-of-zostavax-vaccination-in-rheumatoid-arthritis-102204https://curecurrent.com/trials/safety-study-of-remsima-infliximab-in-rheumatoid-arthritis-patients-in-jordan-102205https://curecurrent.com/trials/biomarkers-in-rheumatoid-arthritis-treated-with-anti-interleukin-6-therapy-102206https://curecurrent.com/trials/foot-orthotic-for-early-stage-rheumatoid-arthritis-102207https://curecurrent.com/trials/a-study-to-target-the-type-i-ifn-receptor-by-administrating-anifrolumab-in-ra-patients-with-a-high-ifn-signature-tarifni-102208https://curecurrent.com/trials/safety-and-efficacy-of-pf-06650833-in-subjects-with-rheumatoid-arthritis-with-an-inadequate-response-to-methotrexate-102209https://curecurrent.com/trials/impact-of-abbvie-care-patient-support-program-on-clinical-health-economic-and-patient-reported-outcomes-in-crohn-s-disea-102210https://curecurrent.com/trials/prolactin-hormone-in-rheumatoid-arthritis-patients-with-periodontitis-102211https://curecurrent.com/trials/sleep-quality-in-patients-with-rheumatoid-arthritis-102212https://curecurrent.com/trials/safety-and-tolerability-of-herpes-zoster-vaccine-rheumatologic-patients-102213https://curecurrent.com/trials/application-of-68ga-neb-pet-imaging-in-the-diagnosis-and-evaluation-of-lymphatic-disorders-102214https://curecurrent.com/trials/evaluating-the-role-of-intra-articular-injections-of-platelet-rich-plasma-prp-in-patients-with-rheumatoid-arthritis-102215https://curecurrent.com/trials/pk-pd-safety-and-efficacy-of-sait101-versus-mabthera-versus-rituxan-in-patients-with-rheumatoid-arthritis-102216https://curecurrent.com/trials/amg-162-denosumab-phase-3-study-desirable-study-in-participants-with-rheumatoid-arthritis-on-disease-modifying-antirheum-102217https://curecurrent.com/trials/study-to-describe-real-world-drug-retention-rate-of-the-tocilizumab-at-one-year-102218https://curecurrent.com/trials/the-turkish-cross-cultural-adaptation-validity-and-reliability-of-vmpci-102219https://curecurrent.com/trials/study-to-compare-the-efficacy-and-safety-of-celbesta-and-celebrex-in-patients-with-rheumatoid-arthritis-102220https://curecurrent.com/trials/clinical-study-to-evaluate-the-pharmacokinetic-profiles-and-safety-of-ckd-374-5-mg-in-healthy-volunteers-102221https://curecurrent.com/trials/study-to-evaluate-the-bioequivalence-of-pfizer-korea-inc-xeljanz-5mg-tablet-in-healthy-volunteers-102222https://curecurrent.com/trials/donepezil-attenuate-postoperative-cognitive-dysfunction-102223https://curecurrent.com/trials/a-study-of-ro7123520-to-evaluate-the-safety-and-efficacy-in-participants-with-moderately-to-severely-active-rheumatoid-a-102224https://curecurrent.com/trials/an-open-label-study-to-assess-the-rate-of-failure-of-an-enbrel-etanercept-sureclick-auto-injector-in-subjects-with-rheum-102225https://curecurrent.com/trials/lacripep-in-subjects-with-dry-eye-associated-with-primary-sj-gren-s-syndrome-102226https://curecurrent.com/trials/enhancing-patient-ability-to-understand-and-utilize-complex-information-concerning-medication-self-management-102227https://curecurrent.com/trials/t-cells-and-tnf-tumor-necrosis-factor-the-impact-of-tnf-blockade-102228https://curecurrent.com/trials/pulmozyme-for-sjogren-s-associated-cough-102229https://curecurrent.com/trials/cellular-biocellular-regenerative-therapy-in-musculoskeletal-pain-dysfunction-degenerative-or-inflammatory-disease-102230https://curecurrent.com/trials/characteristics-of-rheumatoid-arthritis-patients-with-atlantoaxial-synovitis-detected-by-plain-x-ray-and-mri-102231https://curecurrent.com/trials/vaccine-coverage-and-primary-sj-gren-syndrome-102232https://curecurrent.com/trials/impact-of-clinical-pharmacy-services-provided-for-patients-with-active-rheumatoid-arthritis-102233https://curecurrent.com/trials/post-marketing-use-of-ct-p13-infliximab-for-standard-of-care-treatment-of-rheumatoid-diseases-who-are-na-ve-to-biologics-102234https://curecurrent.com/trials/comparative-pharmacokinetic-pharmacodynamic-safety-and-efficacy-study-of-three-anti-cd20-monoclonal-antibodies-in-patien-102235https://curecurrent.com/trials/outcome-after-total-knee-arthroplasty-under-general-or-spinal-anesthesia-102236https://curecurrent.com/trials/taperloc-complete-microplasty-vs-taperloc-complete-standard-randomized-controlled-study-on-bone-mineral-density-102237https://curecurrent.com/trials/prediction-medical-device-for-rheumatoid-arthritis-predira-102238https://curecurrent.com/trials/low-dose-naltrexone-for-chronic-pain-in-osteoarthritis-and-inflammatory-arthritis-102239https://curecurrent.com/trials/a-study-of-jhl1101-versus-mabthera-in-subjects-with-severe-rheumatoid-arthritis-102240https://curecurrent.com/trials/reu-stop-effect-of-intensive-smoking-cessation-intervention-on-smoking-cessation-and-disease-activity-in-patients-with-r-102241https://curecurrent.com/trials/clinically-important-changes-in-rheumatoid-arthritis-102242https://curecurrent.com/trials/a-study-evaluating-the-efficacy-and-safety-of-ckd-506-in-adult-subjects-with-moderate-to-severe-rheumatoid-arthritis-and-102243https://curecurrent.com/trials/cobiprostone-prevention-of-nsaid-induced-gastroduodenal-injury-102244https://curecurrent.com/trials/rabiopred-a-validation-study-of-theranostic-test-to-predict-treatment-response-of-anti-tnf-biologicals-in-rheumatoid-art-102245https://curecurrent.com/trials/msb11022-in-moderate-to-severe-rheumatoid-arthritis-102246https://curecurrent.com/trials/identification-of-novel-molecular-targets-for-rheumatoid-arthritis-patients-102247https://curecurrent.com/trials/serum-calprotectin-level-in-patients-with-rheumatoid-arthritis-and-osteoarthritis-102248https://curecurrent.com/trials/natural-history-of-salivary-gland-dysfunction-and-sjogren-s-syndrome-102249https://curecurrent.com/trials/99mtc-rhannexin-v-128-in-diagnosis-of-spondyloarthritis-102250https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-sm03-in-patients-with-rheumatoid-arthritis-receiving-methotrexate-102251https://curecurrent.com/trials/a-non-interventional-study-in-patients-with-moderate-to-severe-rheumatoid-arthritis-treated-with-roactemra-actemra-tocil-102252https://curecurrent.com/trials/non-interventional-study-of-tocilizumab-subcutaneous-sc-monotherapy-in-participants-with-rheumatoid-arthritis-ra-102253https://curecurrent.com/trials/denosumab-for-glucocorticoid-treated-children-with-rheumatic-disorders-102254https://curecurrent.com/trials/effectiveness-and-adherence-of-golimumab-in-rheumatoid-arthritis-102255https://curecurrent.com/trials/methotrexate-withdrawal-study-of-tofacitinib-modified-release-formulation-in-subjects-with-rheumatoid-arthritis-102256https://curecurrent.com/trials/therapy-of-antibody-mediated-autoimmune-diseases-by-bortezomib-tavab-102257https://curecurrent.com/trials/phase-clinical-trial-of-gerilimzumab-injection-in-healthy-subjects-102258https://curecurrent.com/trials/clinical-comparative-study-to-evaluate-the-efficacy-and-safety-of-recombinant-anti-tnf-alpha-antibodies-for-injection-102259https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-tolerability-of-multiple-doses-of-gerilimzumab-in-rheumatoid-arthritis-patients-102260https://curecurrent.com/trials/methotrexate-and-statins-with-methotrexate-alone-in-the-treatment-of-rheumatoid-arthritis-102261https://curecurrent.com/trials/pilot-study-for-testing-safety-of-repetitive-magnetic-stimulation-for-treatment-of-dry-eye-102262https://curecurrent.com/trials/evaluation-of-sc-injected-tc-99m-tilmanocept-localization-in-active-ra-subjects-by-spect-and-spect-ct-imaging-102263https://curecurrent.com/trials/sirolimus-for-autoimmune-disease-of-blood-cells-102264https://curecurrent.com/trials/a-pharmacokinetic-pharmacodynamic-study-comparing-pf-05280586-to-rituximab-in-subjects-with-active-rheumatoid-arthritis-102265https://curecurrent.com/trials/a-clinical-trial-study-of-knee-system-in-primary-total-knee-arthroplasty-in-china-102266https://curecurrent.com/trials/regional-registry-based-biobank-development-and-pharmacogenetic-analysis-in-rheumatoid-arthritis-102267https://curecurrent.com/trials/tocilizumab-remission-in-early-ra-102268https://curecurrent.com/trials/post-marketing-observational-study-to-evaluate-the-incremental-impact-of-abbvie-s-patient-support-program-on-patient-rep-102269https://curecurrent.com/trials/rosuvastatin-in-rheumatoid-arthritis-rora-102270https://curecurrent.com/trials/study-to-compare-the-efficacy-of-tocilizumab-with-or-without-glucocorticoid-discontinuation-in-rheumatoid-arthritis-part-102271https://curecurrent.com/trials/etanercept-and-methotrexate-in-patients-to-induce-remission-in-early-arthritis-empire-102272https://curecurrent.com/trials/infliximab-as-induction-therapy-in-early-rheumatoid-arthritis-idea-102273https://curecurrent.com/trials/targeted-ultrasound-in-rheumatoid-arthritis-102274https://curecurrent.com/trials/etoricoxib-vs-aceclofenac-in-the-treatment-of-patients-with-rheumatoid-arthritis-102275https://curecurrent.com/trials/observational-registry-of-patients-with-rheumatoid-arthritis-spondyloarthritis-using-biological-or-targeted-synthetic-dm-102276https://curecurrent.com/trials/study-to-test-the-safe-and-effective-use-of-an-e-device-for-the-self-injection-of-certolizumab-pegol-solution-by-subject-102277https://curecurrent.com/trials/oral-health-needs-assessment-of-sjogren-s-syndrome-and-salivary-gland-dysfunction-cohorts-and-healthy-volunteers-evaluat-102278https://curecurrent.com/trials/duke-autoimmunity-in-pregnancy-registry-102279https://curecurrent.com/trials/a-study-of-experimental-medication-bms-986251-taken-by-mouth-in-healthy-participants-and-patients-with-average-to-very-s-102280https://curecurrent.com/trials/use-of-cross-linked-donor-corneas-as-carriers-for-the-boston-keratoprosthesis-102281https://curecurrent.com/trials/perioperative-flare-in-ra-characterization-of-clinical-and-biological-features-102282https://curecurrent.com/trials/a-study-of-ly3337641-in-rheumatoid-arthritis-102283https://curecurrent.com/trials/tolera-tolerance-enhancement-in-ra-102284https://curecurrent.com/trials/bisphosphonates-for-the-treatment-of-seropositive-musculoskeletal-complaints-102285https://curecurrent.com/trials/prom-collected-via-a-smartphone-app-versus-a-touch-screen-solution-among-patients-with-inflammatory-arthritis-102286https://curecurrent.com/trials/comparison-of-combination-disease-modifying-antirheumatic-drugs-with-methotrexate-therapy-in-early-rheumatoid-arthritis-102287https://curecurrent.com/trials/a-clinical-trial-to-evaluate-the-safety-and-efficacy-of-traditional-chinese-medicine-in-sj-gren-s-syndrome-102288https://curecurrent.com/trials/preventive-ivig-therapy-for-congenital-heart-block-102289https://curecurrent.com/trials/comparing-the-efficacy-of-periarticular-bone-structure-in-patients-treated-with-either-tocilizumab-or-tumor-necrosis-fac-102290https://curecurrent.com/trials/safety-and-efficacy-study-of-etanercept-enbrel-in-children-with-systemic-onset-juvenile-rheumatoid-arthritis-102291https://curecurrent.com/trials/oral-baricitinib-ly3009104-treatment-in-japanese-participants-with-active-rheumatoid-arthritis-on-background-methotrexat-102292https://curecurrent.com/trials/a-study-in-participants-with-moderate-to-severe-rheumatoid-arthritis-102293https://curecurrent.com/trials/non-interventional-multicenter-bicontact-e-pmcf-study-102294https://curecurrent.com/trials/a-moderate-to-severe-rheumatoid-arthritis-study-102295https://curecurrent.com/trials/a-study-in-moderate-to-severe-rheumatoid-arthritis-102296https://curecurrent.com/trials/a-study-in-moderate-to-severe-rheumatoid-arthritis-participants-102297https://curecurrent.com/trials/cthrc1-abiomarker-in-rheumatoid-arthritis-diagnosis-102298https://curecurrent.com/trials/faecal-analyses-in-rheumatoid-arthritis-therapy-102299https://curecurrent.com/trials/study-of-efficacy-and-safety-of-canakinumab-in-japanese-patients-with-sjia-102300https://curecurrent.com/trials/real-world-outcome-of-adalimumab-on-rheumatoid-arthritis-patients-in-china-102301https://curecurrent.com/trials/autologous-tolerogenic-dendritic-cells-for-treatment-of-patients-with-rheumatoid-arthritis-102302https://curecurrent.com/trials/impact-of-life-events-and-psychological-stress-in-rheumatoid-arthritis-set-up-case-control-study-within-a-multifactorial-102303https://curecurrent.com/trials/a-study-of-baricitinib-ly3009104-in-participants-with-rheumatoid-arthritis-ra-102304https://curecurrent.com/trials/a-multi-site-study-to-evaluate-the-safety-and-effect-of-study-drug-on-participants-with-rheumatoid-arthritis-102305https://curecurrent.com/trials/low-dose-recombinant-human-il-2-for-the-treatment-of-rheumatoid-arthritis-102306https://curecurrent.com/trials/very-early-versus-delayed-etanercept-in-patients-with-ra-102307https://curecurrent.com/trials/monitoring-the-immuological-toxicity-of-drugs-102308https://curecurrent.com/trials/efficacy-and-safety-of-abatacept-in-patients-with-primary-sj-gren-s-syndrome-102309https://curecurrent.com/trials/study-to-assess-if-abp710-is-safe-effective-in-treating-moderate-to-severe-rheumatoid-arthritis-compared-to-infliximab-102310https://curecurrent.com/trials/scintigraphic-detection-of-the-biodistribution-of-tumor-necrosis-factor-with-a-radiolabeled-anti-tnf-in-patients-with-ac-102311https://curecurrent.com/trials/optimal-mtx-dose-with-folic-acid-randomized-case-control-trial-102312https://curecurrent.com/trials/a-dose-range-finding-study-for-alx-0061-combination-therapy-in-subjects-with-rheumatoid-arthritis-102313https://curecurrent.com/trials/a-phase-iib-study-for-alx-0061-monotherapy-in-subjects-with-rheumatoid-arthritis-102314https://curecurrent.com/trials/analysis-of-human-knee-joint-fluid-using-metabonomic-genomic-and-tribology-techniques-102315https://curecurrent.com/trials/clinical-study-of-escitalopram-oxalate-combined-with-tavns-in-depression-and-concomitant-inflammatory-symptoms-102316https://curecurrent.com/trials/prospective-evaluation-of-the-radiographic-efficacy-of-enbrel-102317https://curecurrent.com/trials/study-of-the-articular-microbiota-in-rheumatoid-arthritis-102318https://curecurrent.com/trials/safety-tolerability-and-efficacy-of-mbs2320-in-patients-with-rheumatoid-arthritis-102319https://curecurrent.com/trials/atorvastatin-vs-colchicine-in-decrease-of-troponin-i-of-high-sensitivity-in-patients-with-rheumatoid-arthritis-102320https://curecurrent.com/trials/oral-metagenomic-biomarkers-in-rheumatoid-arthritis-102321https://curecurrent.com/trials/a-study-of-ocrelizumab-compared-to-placebo-in-patients-with-active-rheumatoid-arthritis-who-don-t-have-a-response-to-ant-102322https://curecurrent.com/trials/lipopolysaccharide-lps-or-granulocyte-macrophage-colony-stimulating-factor-gm-csf-challenge-study-on-healthy-subjects-102323https://curecurrent.com/trials/special-investigation-all-case-survey-in-patients-with-juvenile-idiopathic-arthritis-102324https://curecurrent.com/trials/rheumatoid-arthritis-response-to-methotrexate-102325https://curecurrent.com/trials/safety-and-efficacy-of-etanercept-recombinant-human-tumor-necrosis-factor-receptor-fusion-protein-tnfr-fc-in-children-wi-102326https://curecurrent.com/trials/etanercept-plus-methotrexate-versus-methotrexate-alone-in-children-with-polyarticular-course-juvenile-rheumatoid-arthrit-102327https://curecurrent.com/trials/a-phase-i-study-of-icp-022-in-healthy-subjects-102328https://curecurrent.com/trials/an-open-label-extension-study-assessing-the-long-term-efficacy-and-safety-of-alx-0061-in-subjects-with-rheumatoid-arthri-102329https://curecurrent.com/trials/adipokines-as-predictors-of-foot-function-pain-and-disability-in-patients-with-rheumatoid-arthritis-102330https://curecurrent.com/trials/rheumatoid-arthritis-patients-and-porphyromonas-gingivalis-102331https://curecurrent.com/trials/impact-of-nurse-led-programme-with-carotid-ultrasound-on-addressing-cardiovascular-risk-in-patients-with-arthritis-102332https://curecurrent.com/trials/april-abatacept-in-rheumatoid-arthritis-ild-102333https://curecurrent.com/trials/safety-tolerability-pk-and-pd-of-biosimilar-drug-ritumax-compared-to-original-drug-mabthera-102334https://curecurrent.com/trials/study-to-assess-the-injection-site-pain-associated-with-a-new-etanercept-formulation-in-adults-with-rheumatoid-arthritis-102335https://curecurrent.com/trials/yoga-as-self-care-for-arthritis-in-minority-communities-102336https://curecurrent.com/trials/sidus-stem-free-shoulder-ide-study-102337https://curecurrent.com/trials/comprehensive-assessment-of-subclinical-atherosclerosis-in-patients-with-rheumatoid-arthritis-102338https://curecurrent.com/trials/ss-specific-4-patients-study-of-pediatric-efficacy-and-safety-with-first-line-use-of-canakinumab-102339https://curecurrent.com/trials/ultrasonography-as-a-biomarker-in-early-rheumatoid-arthritis-102340https://curecurrent.com/trials/to-evaluate-the-pharmacokinetics-and-safety-of-oral-administration-of-br9001-compared-with-br900a-in-healthy-subjects-102341https://curecurrent.com/trials/sleep-and-exercise-in-rheumatoid-arthritis-102342https://curecurrent.com/trials/tolerance-pharmacokinetics-and-preliminary-efficacy-of-t0001-in-ra-rheumatoid-arthritis-102343https://curecurrent.com/trials/adherence-rate-to-dmards-in-egyptian-patients-with-ra-102344https://curecurrent.com/trials/an-evaluation-of-the-optimal-dose-of-tofacitinib-needed-to-achieve-low-disease-activity-lda-or-clinical-remission-in-pat-102345https://curecurrent.com/trials/a-belgian-registry-of-humira-adalimumab-in-rheumatoid-arthritis-psoriatic-arthritis-and-ankylosing-spondylitis-proact-102346https://curecurrent.com/trials/cormet-post-pma-study-new-enrollment-102347https://curecurrent.com/trials/assessment-of-clinical-effectiveness-and-safety-of-adalimumab-and-high-dose-methotrexate-in-routine-clinical-practice-102348https://curecurrent.com/trials/drug-outcome-survey-for-biological-treatments-in-rheumatoid-arthritis-an-observational-study-dose-102349https://curecurrent.com/trials/role-of-the-ans-dysregulation-in-the-persistence-of-fatigue-in-rheumatoid-arthritis-patients-treated-with-anti-tnf-102350https://curecurrent.com/trials/comparison-of-chs-0214-to-enbrel-etanercept-in-patients-with-rheumatoid-arthritis-ra-102351https://curecurrent.com/trials/evaluation-of-pharmacokinetics-and-safety-of-gsk3196165-in-combination-with-methotrexate-in-japanese-subjects-with-rheum-102352https://curecurrent.com/trials/a-phase-4-trial-assessing-the-impact-of-residual-inflammation-detected-via-imaging-techniques-drug-levels-and-patient-ch-102353https://curecurrent.com/trials/estimation-of-gingival-crevicular-level-of-ykl40-102354https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-of-enbrel-registered-etanercept-over-a-period-of-12-months-in-the-routine-treatment-of-102355https://curecurrent.com/trials/a-multicener-postmarketing-study-evaluating-the-transfer-of-cimzia-from-the-mother-to-the-infant-via-the-placenta-102356https://curecurrent.com/trials/umbilical-cord-tissue-derived-mesenchymal-stem-cells-for-rheumatoid-arthritis-102357https://curecurrent.com/trials/an-observational-study-of-the-effectiveness-of-adalimumab-on-health-and-disability-outcomes-in-new-zealand-patients-with-102358https://curecurrent.com/trials/circadian-ra-study-in-rheumatoid-arthritis-subjects-102359https://curecurrent.com/trials/comparative-clinical-trial-of-efficacy-and-safety-of-bcd-055-and-remicade-in-combination-with-methotrexate-in-patients-w-102360https://curecurrent.com/trials/survivorship-and-patient-outcomes-of-primary-total-hip-arthroplasty-with-the-ovation-hip-system-102361https://curecurrent.com/trials/abatacept-and-the-risk-of-cancer-a-case-non-case-analysis-in-vigibase-102362https://curecurrent.com/trials/interstitial-lung-disease-in-early-rheumatoid-arthritis-102363https://curecurrent.com/trials/investigate-the-development-and-progression-of-lung-disease-in-rheumatoid-arthritis-over-time-102364https://curecurrent.com/trials/uromodulin-in-rheumatoid-arthritis-102365https://curecurrent.com/trials/efficacy-and-safety-study-of-bms-986142-in-patients-with-moderate-to-severe-rheumatoid-arthritis-102366https://curecurrent.com/trials/metformin-use-in-rheumatoid-arthritis-102367https://curecurrent.com/trials/quality-of-life-related-to-health-in-spa-users-102368https://curecurrent.com/trials/efficacy-and-safety-of-fecal-microbiota-transplantation-in-patients-with-rheumatoid-arthritis-refractory-to-methotrexate-102369https://curecurrent.com/trials/comparing-effect-of-topical-tacrolimus-0-03-versus-cyclosporine-0-05-in-dry-eyes-of-secondary-sjogren-syndrome-102370https://curecurrent.com/trials/cd73-th1-17-in-rheumatoid-arthritis-and-psoriatic-arthritis-102371https://curecurrent.com/trials/musculoskeletal-ultrasound-in-predicting-early-dose-titration-with-tocilizumab-102372https://curecurrent.com/trials/a-long-term-extension-study-of-wa19926-nct01007435-of-tocilizumab-roactemra-actemra-in-participants-with-early-moderate-102373https://curecurrent.com/trials/dna-exome-sequencing-tcm-for-sj-gren-s-syndrome-102374https://curecurrent.com/trials/long-term-safety-and-efficacy-of-sirukumab-in-participants-with-ra-completing-studies-cnto136ara3002-or-cnto136ara3003-102375https://curecurrent.com/trials/inflammation-and-the-heart-102376https://curecurrent.com/trials/the-standard-care-versus-celecoxib-outcome-trial-102377https://curecurrent.com/trials/an-observational-study-on-long-term-efficacy-and-safety-of-roactemra-actemra-tocilizumab-in-patients-with-moderate-to-se-102378https://curecurrent.com/trials/implantology-and-sj-gren-s-syndrome-102379https://curecurrent.com/trials/pictorial-representation-of-illness-and-self-measure-102380https://curecurrent.com/trials/remission-induction-in-very-early-rheumatoid-arthritis-102381https://curecurrent.com/trials/evaluation-of-influenza-a-h3n2-vaccine-in-patients-with-rheumatologic-diseases-102382https://curecurrent.com/trials/yellow-fever-vaccine-in-patients-with-rheumatic-diseases-102383https://curecurrent.com/trials/discrepancies-between-patients-and-physicians-in-their-perceptions-of-rheumatoid-arthritis-disease-activity-102384https://curecurrent.com/trials/a-study-of-flt3-ligand-levels-in-sj-grens-syndrome-102385https://curecurrent.com/trials/an-evaluation-of-the-impact-of-a-single-dose-of-p-552-on-oral-mucosal-wetness-102386https://curecurrent.com/trials/does-abatacept-induce-regulatory-b-cells-in-patients-with-rheumatoid-arthritis-102387https://curecurrent.com/trials/salivary-biomarkers-for-sj-gren-s-syndrome-detection-102388https://curecurrent.com/trials/tocilizumab-real-life-human-factors-rlhfs-validation-study-102389https://curecurrent.com/trials/synovitis-and-therapy-response-in-inflammatory-arthritis-with-contrast-enhanced-ultrasound-102390https://curecurrent.com/trials/cx611-0101-eascs-intravenous-administration-to-refractory-rheumatoid-arthritis-patients-102391https://curecurrent.com/trials/resistance-exercise-in-rheumatic-disease-102392https://curecurrent.com/trials/bloodstream-infections-in-patients-with-rheumatoid-arthritis-102393https://curecurrent.com/trials/the-press-ra-protein-and-resistance-exercise-supplementation-study-for-rheumatoid-arthritis-102394https://curecurrent.com/trials/patient-satisfaction-after-silicone-metacarpophalangeal-arthroplasty-102395https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-taci-antibody-fusion-protein-injection-rc18-in-subjects-with-inadequate-response-t-102396https://curecurrent.com/trials/a-multiple-dose-of-hl237-in-healthy-male-subject-102397https://curecurrent.com/trials/acp-196-versus-placebo-in-subjects-with-rheumatoid-arthritis-on-background-methotrexate-102398https://curecurrent.com/trials/an-multicentre-clinical-study-to-evaluate-the-usability-and-safety-of-the-pre-filled-pen-and-pre-filled-syringe-of-sb5-i-102399https://curecurrent.com/trials/journey-ii-bi-cruciate-stabilized-bcs-total-knee-system-retrospective-study-102400https://curecurrent.com/trials/safety-and-efficacy-of-mk-8457-and-methotrexate-mtx-in-participants-with-active-rheumatoid-arthritis-despite-mtx-therapy-102401https://curecurrent.com/trials/a-study-to-compare-fkb327-long-term-safety-efficacy-and-immunogenicity-with-humira-in-rheumatoid-arthritis-patients-102402https://curecurrent.com/trials/g7-acetabular-system-vs-exceed-abt-acetabular-system-in-tha-102403https://curecurrent.com/trials/outcomes-study-of-the-tm-humeral-stem-used-in-primary-total-or-hemi-shoulder-arthroplasty-102404https://curecurrent.com/trials/embrace-sc-observational-study-of-subcutaneous-sc-tocilizumab-alone-or-in-combination-with-conventional-disease-modifyin-102405https://curecurrent.com/trials/clinical-efficacy-of-tnf-kinoid-in-patients-with-rheumatoid-arthritis-102406https://curecurrent.com/trials/real-world-outcome-of-rheumatoid-arthritis-patients-in-korea-on-adalimumab-102407https://curecurrent.com/trials/phase-1-trial-of-type-ii-collagen-cii-apl-a12-in-rheumatoid-arthritis-patients-102408https://curecurrent.com/trials/musculoskeletal-ultrasound-assessment-of-therapeutic-response-of-tofacitinib-in-rheumatoid-arthritis-patients-102409https://curecurrent.com/trials/a-dose-range-finding-study-of-jnj-38518168-in-patients-with-active-rheumatoid-arthritis-in-spite-of-treatment-with-metho-102410https://curecurrent.com/trials/real-world-outcome-of-adalimumab-on-rheumatoid-arthritis-patients-in-taiwan-102411https://curecurrent.com/trials/intra-articular-glucocorticoid-treatment-of-the-elbow-102412https://curecurrent.com/trials/evaluation-of-stem-cell-therapy-effects-on-the-immune-response-in-rheumatoid-arthritis-patients-102413https://curecurrent.com/trials/entecavir-for-biological-agents-associated-hbv-reactivation-in-inflammatory-arthritis-patients-102414https://curecurrent.com/trials/fibrocytes-in-early-and-longstanding-rheumatoid-arthritis-102415https://curecurrent.com/trials/a-study-exploring-the-safety-tolerability-and-efficacy-of-a-28-day-course-followed-by-an-additional-56-day-course-of-ita-102416https://curecurrent.com/trials/meir-medical-center-rheumatologic-biobank-102417https://curecurrent.com/trials/comparison-of-treatments-following-total-knee-replacement-102418https://curecurrent.com/trials/a-nutrition-intervention-for-arthritis-3-wccr-arth3-102419https://curecurrent.com/trials/a-study-of-japanese-rheumatoid-arthritis-participants-102420https://curecurrent.com/trials/zoledronic-acid-in-rheumatoid-arthritis-102421https://curecurrent.com/trials/electronic-and-lab-pre-screening-of-new-rheumatology-patients-with-rheumatoid-arthritis-102422https://curecurrent.com/trials/probiotics-as-a-prophylaxis-to-prevent-clinical-manifestations-of-oral-candidosis-in-patients-with-sjogren-s-syndrome-102423https://curecurrent.com/trials/minor-salivary-gland-transplantation-for-cicatrizing-conjunctivitis-102424https://curecurrent.com/trials/effects-of-clinical-pilates-exercises-in-patients-with-rheumatoid-arthritis-102425https://curecurrent.com/trials/serum-biomarkers-analysis-in-patients-with-ar-treated-with-anti-tmf-102426https://curecurrent.com/trials/predictive-analytics-for-theranosis-in-ra-102427https://curecurrent.com/trials/safety-and-effect-on-quality-of-life-work-productivity-of-humira-in-patients-with-rheumatoid-arthritis-102428https://curecurrent.com/trials/a-safety-and-pharmacokinetics-study-in-participants-with-rheumatoid-arthritis-102429https://curecurrent.com/trials/namilumab-vs-adalimumab-in-participants-with-moderate-to-severe-early-rheumatoid-arthritis-inadequately-responding-to-me-102430https://curecurrent.com/trials/eccentric-exercise-and-cachexia-in-rheumatoid-arthritis-102431https://curecurrent.com/trials/assessment-of-tender-swollen-joints-count-score-performed-by-a-rheumatologist-and-rheumatology-nurses-in-patients-with-r-102432https://curecurrent.com/trials/tai-chi-in-rheumatoid-arthritis-taichira-102433https://curecurrent.com/trials/ultrasound-impact-in-rheumatoid-arthritis-patient-reported-outcomes-102434https://curecurrent.com/trials/safety-tolerability-and-relative-bioavailability-study-of-bms-986195-in-healthy-subjects-102435https://curecurrent.com/trials/comparing-the-effectiveness-of-a-treat-to-target-t2t-disease-management-strategy-vs-routine-care-rc-in-adult-patients-wi-102436https://curecurrent.com/trials/rheumatoid-arthritis-extension-trial-for-subjects-who-have-participated-in-other-pf-05280586-trials-reflections-b328-04-102437https://curecurrent.com/trials/assessment-of-rheumatoid-arthritis-psoriatic-arthritis-ankylosing-spondylitis-plaque-psoriasis-crohn-s-disease-and-ulcer-102438https://curecurrent.com/trials/efficiency-of-a-nurse-led-self-management-education-intervention-in-promoting-safety-knowledge-and-skills-of-patients-wi-102439https://curecurrent.com/trials/adelphi-primary-sjogren-s-syndrome-pss-disease-specific-programme-dsp-102440https://curecurrent.com/trials/vega-prospective-kiel-102441https://curecurrent.com/trials/a-study-of-pf-06410293-adalimumab-pfizer-and-adalimumab-humira-in-combination-with-methotrexate-in-subjects-with-active-102442https://curecurrent.com/trials/targeted-treatment-early-with-etanercept-methotrexate-vs-t2t-care-for-dmard-na-ve-early-ra-patients-based-on-na-ve-t-cel-102443https://curecurrent.com/trials/effectiveness-in-daily-practice-of-different-treatment-strategies-for-early-rheumatoid-arthritis-102444https://curecurrent.com/trials/the-effect-of-corticotrophin-acth-in-combination-with-methotrexate-in-newly-diagnosed-rheumatoid-arthritis-patients-102445https://curecurrent.com/trials/safety-study-of-abatacept-to-treat-rheumatoid-arthritis-b-102446https://curecurrent.com/trials/pain-evaluation-in-rheumatoid-arthritis-102447https://curecurrent.com/trials/do-inflammatory-arthritis-inpatients-receiving-group-music-therapy-improve-pain-compared-to-music-listening-102448https://curecurrent.com/trials/tracking-biologics-along-the-silk-road-102449https://curecurrent.com/trials/gender-solutions-natural-knee-post-market-study-102450https://curecurrent.com/trials/the-safety-and-effects-of-mesenchymal-stem-cell-mscs-in-the-treatment-of-rheumatoid-arthritis-102451https://curecurrent.com/trials/characterization-of-the-effect-of-tocilizumab-in-vivo-and-in-vitro-on-t-follicular-helper-cells-in-rheumatoid-arthritis-102452https://curecurrent.com/trials/total-knee-arthroplasty-tka-cemented-versus-cementless-tibial-prosthesis-study-102453https://curecurrent.com/trials/study-to-assess-safety-and-efficacy-of-anti-interleukin-6-receptor-il6r-nanobody-in-rheumatoid-arthritis-ra-patients-102454https://curecurrent.com/trials/alx-0061-phase-i-bioavailability-study-in-healthy-volunteers-102455https://curecurrent.com/trials/characterization-of-the-phenotypic-markers-of-b-cell-lymphocytes-in-rheumatoid-arthritis-102456https://curecurrent.com/trials/safety-and-efficacy-of-vagus-nerve-stimulator-in-patients-with-rheumatoid-arthritis-ra-102457https://curecurrent.com/trials/a-long-term-safety-extension-study-chs-0214-05-102458https://curecurrent.com/trials/therapeutic-drug-monitoring-of-tocilizumab-in-rheumatoid-arthritis-102459https://curecurrent.com/trials/augment-injectable-bone-graft-compared-to-autologous-bone-graft-as-a-bone-regeneration-device-in-hindfoot-fusions-102460https://curecurrent.com/trials/clinical-trial-to-compare-treatment-with-gp2017-and-humira-in-patients-with-rheumatoid-arthritis-102461https://curecurrent.com/trials/study-of-cp-690-550-versus-placebo-in-rheumatoid-arthritis-patients-on-background-methotrexate-with-inadequate-response-102462https://curecurrent.com/trials/masitinib-in-refractory-active-rheumatoid-arthritis-102463https://curecurrent.com/trials/effects-of-growth-hormone-in-chronically-ill-children-102464https://curecurrent.com/trials/characterization-of-non-steroidal-anti-inflammatory-drug-nsaid-intake-in-rheumatoid-arthritis-ra-participants-on-tociliz-102465https://curecurrent.com/trials/masitinib-in-combination-with-methotrexate-in-treatment-of-patients-with-active-rheumatoid-arthritis-102466https://curecurrent.com/trials/niclosamide-with-etanercept-in-rheumatoid-arthritis-102467https://curecurrent.com/trials/effects-of-different-antirheumatic-treatments-of-arthritis-on-antibody-response-following-vaccination-using-prevenar-102468https://curecurrent.com/trials/a-study-of-ly3090106-in-participants-with-sj-gren-s-syndrome-ss-102469https://curecurrent.com/trials/efficacy-of-oral-ab1010-in-adult-patients-with-active-rheumatoid-arthritis-102470https://curecurrent.com/trials/statins-and-arbs-on-rheumatoid-activity-102471https://curecurrent.com/trials/effect-of-some-drugs-on-rheumatoid-arithritis-activity-102472https://curecurrent.com/trials/a-study-of-tocilizumab-roactemra-actemra-in-monotherapy-or-in-combination-with-methotrexate-or-other-non-biologic-dmards-102473https://curecurrent.com/trials/a-study-for-patients-with-rheumatoid-arthritis-on-methotrexate-mtx-with-an-inadequate-response-to-tnf-inhibitor-therapy-102474https://curecurrent.com/trials/long-term-assessment-of-safety-and-efficacy-of-bi-695501-in-patients-with-rheumatoid-arthritis-102475https://curecurrent.com/trials/comparison-between-rebamipide-2-versus-autologous-serum-102476https://curecurrent.com/trials/study-to-assess-the-efficacy-and-safety-of-pf-06651600-in-subjects-with-rheumatoid-arthritis-with-an-inadequate-response-102477https://curecurrent.com/trials/study-with-etanercept-focusing-on-remission-and-predictability-of-remission-in-real-life-clinical-practice-102478https://curecurrent.com/trials/study-to-observe-the-safety-and-efficacy-of-etanercept-enbrel-in-patients-with-moderately-active-rheumatoid-arthritis-in-102479https://curecurrent.com/trials/novel-imaging-markers-for-rheumatoid-arthritis-102480https://curecurrent.com/trials/trial-of-ginsenoside-compound-k-gck-tablet-in-patients-with-rheumatoid-arthritis-102481https://curecurrent.com/trials/changes-in-ultrasonographic-assessment-of-inflammation-upon-initiation-of-adalimumab-combination-therapy-in-chinese-rheu-102482https://curecurrent.com/trials/a-comparison-of-two-surgical-techniques-using-the-unity-knee-total-knee-system-102483https://curecurrent.com/trials/post-pma-approval-study-10-year-follow-up-ide-subjects-102484https://curecurrent.com/trials/topical-tripterygium-wilfordii-gel-for-moderate-activity-rheumatoid-arthritis-102485https://curecurrent.com/trials/comparison-of-the-safety-and-pk-of-syn060-to-humira-in-healthy-adult-subjects-102486https://curecurrent.com/trials/immunoregulatory-mechanisms-of-treg-cells-induced-by-tocilizumab-102487https://curecurrent.com/trials/art-i02-in-patients-with-rheumatoid-arthritis-with-inflamed-wrists-102488https://curecurrent.com/trials/enalapril-maleate-on-arterial-stiffness-in-rheumatoid-arthritis-102489https://curecurrent.com/trials/a-single-dose-clinical-trial-to-study-the-safety-of-art-i02-in-patients-with-arthritis-102490https://curecurrent.com/trials/a-study-of-subcutaneous-tocilizumab-as-monotherapy-and-or-in-combination-with-non-biologic-disease-modifying-anti-rheuma-102491https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-pharmacokinetic-profile-of-a-p38-inhibitor-ph-797804-in-subjects-with-rheumatoid-arth-102492https://curecurrent.com/trials/reconstitution-of-cd4-cd25highcd127low-tcell-102493https://curecurrent.com/trials/investigation-of-the-safety-and-efficacy-of-iguratimod-in-patients-with-rheumatoid-arthritis-102494https://curecurrent.com/trials/dexamethasone-irrigation-of-the-parotid-glands-in-primary-sj-gren-s-syndrome-subjects-102495https://curecurrent.com/trials/phase-i-study-of-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-multiple-intravenously-administered-do-102496https://curecurrent.com/trials/disease-activity-in-ra-and-sle-patients-and-its-relation-to-muscle-performance-fatigue-and-blood-parameters-102497https://curecurrent.com/trials/a-study-of-tocilizumab-roactemra-in-tocilizumab-naive-participants-with-rheumatoid-arthritis-and-inadequate-response-to-102498https://curecurrent.com/trials/a-randomized-multi-center-biomarker-trial-to-predict-therapeutic-responses-of-patients-with-rheumatoid-arthritis-to-a-sp-102499https://curecurrent.com/trials/long-term-effectiveness-and-safety-of-cp-690-550-for-the-treatment-of-rheumatoid-arthritis-102500https://curecurrent.com/trials/impact-of-the-persistence-of-inflammation-at-doppler-ultrasound-level-on-the-structural-evolution-of-erosion-in-rheumato-102501https://curecurrent.com/trials/circulating-micrornas-as-novel-prognosis-biomarkers-for-rheumatoid-arthritis-102502https://curecurrent.com/trials/coping-skills-training-for-early-rheumatoid-arthritis-102503https://curecurrent.com/trials/a-study-for-japanese-participants-with-rheumatoid-arthritis-ra-102504https://curecurrent.com/trials/benepali-pen-patient-satisfaction-survey-102505https://curecurrent.com/trials/longterm-followup-of-patients-with-rheumatoid-arthritis-treated-with-methotrexate-102506https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-tocilizumab-for-confirmed-rheumatoid-arthritis-ra-participants-in-clinical-practic-102507https://curecurrent.com/trials/6-month-phase-i-ii-open-label-prtx-100-in-previous-rheumatoid-arthritis-study-participants-and-sera-collection-102508https://curecurrent.com/trials/an-open-label-extension-study-of-certolizumab-pegol-in-chinese-patients-with-rheumatoid-arthritis-who-enrolled-in-ra0044-102509https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-tofacitinib-modified-release-tablets-compared-to-tofacitinib-immediate-re-102510https://curecurrent.com/trials/pbr28-pet-and-inflammatory-arthritis-102511https://curecurrent.com/trials/pharmacokinetics-and-dosimetry-of-tc-99m-tilmanocept-following-a-single-intravenous-dose-administration-in-male-and-fema-102512https://curecurrent.com/trials/multi-colored-placido-disk-viability-102513https://curecurrent.com/trials/safety-study-of-abatacept-in-rheumatoid-arthritis-participants-102514https://curecurrent.com/trials/full-mouth-disinfection-and-antibiotics-for-periodontitis-in-high-or-moderate-disease-activity-rheumatoid-arthritis-102515https://curecurrent.com/trials/proof-of-concept-study-to-evaluate-the-efficacy-and-safety-of-bms-931699-lulizumab-or-bms-986142-in-primary-sj-gren-s-sy-102516https://curecurrent.com/trials/a-single-ascending-dose-study-to-assess-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-azd9567-102517https://curecurrent.com/trials/mtx-discontinuation-and-vaccine-response-102518https://curecurrent.com/trials/admission-of-adult-onset-still-disease-patients-in-the-icu-102519https://curecurrent.com/trials/comparative-efficacy-and-safety-study-of-gp2015-and-enbrel-in-patients-with-rheumatoid-arthritis-102520https://curecurrent.com/trials/safety-tolerability-and-efficacy-of-gs-9876-in-participants-with-active-rheumatoid-arthritis-on-background-therapy-with-102521https://curecurrent.com/trials/anxiety-depression-and-rheumatoid-arthritis-102522https://curecurrent.com/trials/a-safety-and-efficacy-study-of-552-02-in-subjects-with-dry-mouth-associated-with-sjogren-s-syndrome-102523https://curecurrent.com/trials/scorpio-non-restricted-geometry-nrg-study-in-japan-102524https://curecurrent.com/trials/tritanium-study-in-japan-102525https://curecurrent.com/trials/dose-finding-study-of-namilumab-in-combination-with-methotrexate-in-participants-with-moderate-to-severe-rheumatoid-arth-102526https://curecurrent.com/trials/a-trial-of-nnc0109-0012-an-anti-il-20-biologic-in-patients-with-active-rheumatoid-arthritis-who-are-inadequate-responder-102527https://curecurrent.com/trials/a-trial-of-nnc0109-0012-an-anti-il-20-biologic-in-patients-with-active-rheumatoid-arthritis-who-are-inadequate-responder-102528https://curecurrent.com/trials/efficacy-of-two-concentrations-of-autologous-serum-for-the-treatment-of-severe-dry-eye-102529https://curecurrent.com/trials/study-to-evaluate-the-ability-of-subjects-with-rheumatoid-arthritis-or-psoriatic-arthritis-to-effectively-use-a-reusable-102530https://curecurrent.com/trials/incb028050-compared-to-background-therapy-in-patients-with-active-rheumatoid-arthritis-ra-with-inadequate-response-to-di-102531https://curecurrent.com/trials/a-non-interventional-study-of-rheumatoid-arthritis-patients-treated-with-roactemra-actemra-tocilizumab-in-monotherapy-102532https://curecurrent.com/trials/preference-between-two-autoinjectors-in-patients-with-rheumatoid-arthritis-and-plaque-psoriasis-treated-with-etanercept-102533https://curecurrent.com/trials/outcomes-data-of-adipose-stem-cells-to-treat-rheumatoid-arthritis-102534https://curecurrent.com/trials/patient-perceived-outcome-after-total-wrist-arthroplasty-with-a-new-total-wrist-arthroplasty-implant-102535https://curecurrent.com/trials/the-corrona-treat-to-target-trial-outcomes-and-feasibility-in-a-us-population-102536https://curecurrent.com/trials/effectiveness-registry-to-study-therapies-for-arthritis-and-inflammatory-conditions-the-corrona-certain-sub-study-102537https://curecurrent.com/trials/efficacy-and-safety-study-of-anbainuo-in-chinese-patients-with-ra-as-in-the-real-world-102538https://curecurrent.com/trials/a-single-ascending-dose-clinical-trial-to-find-the-maximum-tolerable-dose-of-hl237-in-healthy-male-subject-102539https://curecurrent.com/trials/fatigue-in-people-with-rheumatoid-arthritis-randomized-controlled-trial-102540https://curecurrent.com/trials/subject-insights-to-understand-rheumatoid-arthritis-ra-102541https://curecurrent.com/trials/study-of-an-anti-tlr4-mab-in-rheumatoid-arthritis-102542https://curecurrent.com/trials/a-study-is-to-assess-efficacy-and-safety-of-tacrolimus-in-active-rheumatoid-arthritis-patients-who-showed-unsuccessful-r-102543https://curecurrent.com/trials/treatment-of-temporomandibular-joint-osteoarthritis-by-viscosupplement-satisfaction-predictive-factors-102544https://curecurrent.com/trials/study-of-some-risk-factors-for-developing-ra-102545https://curecurrent.com/trials/influence-of-the-radiological-stage-on-the-efficiency-of-viscosupplementation-in-basal-thumb-arthritis-102546https://curecurrent.com/trials/personalized-risk-estimator-for-rheumatoid-arthritis-family-study-102547https://curecurrent.com/trials/methotrexate-rheumatrex-high-dose-special-investigation-regulatory-post-marketing-commitment-plan-102548https://curecurrent.com/trials/rorc-genetic-polymorphism-of-rheumatoid-arthritis-102549https://curecurrent.com/trials/rice-remission-by-intra-articular-injection-plus-certolizumab-102550https://curecurrent.com/trials/a-study-to-compare-meloxicam-im-once-daily-versus-meloxicam-orally-once-daily-in-patients-with-rheumatoid-arthritis-102551https://curecurrent.com/trials/dosing-flexibility-study-in-patients-with-rheumatoid-arthritis-102552https://curecurrent.com/trials/topical-management-of-xerostomia-with-dry-mouth-products-102553https://curecurrent.com/trials/certolizumab-pegol-for-the-treatment-of-patients-with-active-rheumatoid-arthritis-102554https://curecurrent.com/trials/open-label-long-term-safety-study-of-certolizumab-pegol-czp-for-patients-with-rheumatoid-arthritis-102555https://curecurrent.com/trials/assessing-the-use-of-certolizumab-pegol-in-adult-subjects-with-rheumatoid-arthritis-on-the-antibody-response-when-receiv-102556https://curecurrent.com/trials/a-study-to-assess-the-efficacy-of-ro5459072-in-participants-with-primary-sjogren-s-syndrome-102557https://curecurrent.com/trials/a-12-week-study-to-assess-changes-in-joint-inflammation-using-ultrasonography-in-patients-with-rheumatoid-arthritis-ra-102558https://curecurrent.com/trials/open-label-extension-for-patients-coming-from-the-dosing-flexibility-study-in-patients-with-rheumatoid-arthritis-ra-102559https://curecurrent.com/trials/a-comparison-of-two-assessment-tools-in-predicting-treatment-success-of-cimzia-in-rheumatoid-arthritis-subjects-102560https://curecurrent.com/trials/study-to-assess-the-short-and-long-term-efficacy-of-certolizumab-pegol-plus-methotrexate-compared-to-adalimumab-plus-met-102561https://curecurrent.com/trials/rheumatoid-arthritis-tolerance-induction-by-mixed-chimerism-102562https://curecurrent.com/trials/prospective-outcomes-study-vectra-da-guided-care-compared-to-usual-care-102563https://curecurrent.com/trials/a-comparative-study-to-observe-the-effect-of-concomitant-use-of-corticosteroid-treatment-in-rheumatoid-arthritis-ra-part-102564https://curecurrent.com/trials/a-safety-analysis-of-oral-prednisone-as-a-pre-treatment-for-rituximab-in-rheumatoid-arthritis-102565https://curecurrent.com/trials/efficacy-and-safety-of-hqgzwwt-patients-with-rheumatoid-arthritis-102566https://curecurrent.com/trials/fertility-study-of-women-with-chronic-inflammatory-rheumatism-102567https://curecurrent.com/trials/multi-centre-study-to-assess-the-long-term-performance-of-the-deltamotion-cup-system-in-primary-hip-replacement-surgery-102568https://curecurrent.com/trials/anti-tnf-use-during-elective-foot-and-ankle-surgery-in-patients-with-rheumatoid-arthritis-102569https://curecurrent.com/trials/the-efficacy-of-the-traditional-chinese-medicine-niubang-pill-combined-with-methotrexate-on-active-rheumatoid-arthritis-102570https://curecurrent.com/trials/safety-and-efficacy-study-of-m2951-in-participants-with-rheumatoid-arthritis-102571https://curecurrent.com/trials/juanbi-pill-for-rheumatoid-arthritis-102572https://curecurrent.com/trials/efficacy-of-insulin-versus-hyalase-hydro-dissection-of-median-nerve-in-rheumatoid-arthritis-patients-102573https://curecurrent.com/trials/study-evaluating-gerilimzumab-s-safety-efficacy-for-patients-mtx-or-tnf-antagonist-failed-in-rheumatoid-arthritis-102574https://curecurrent.com/trials/assessment-of-the-handling-experience-with-the-bi-695501-autoinjector-in-patients-with-rheumatoid-arthritis-followed-by-102575https://curecurrent.com/trials/a-study-for-patients-with-active-rheumatoid-arthritis-despite-ongoing-methotrexate-therapy-102576https://curecurrent.com/trials/a-study-to-evaluate-the-long-term-safety-and-efficacy-of-lbec0101-in-subjects-with-active-ra-despite-methotrexate-mtx-102577https://curecurrent.com/trials/quality-of-life-and-sj-gren-syndrome-102578https://curecurrent.com/trials/special-investigation-follow-up-survey-of-the-study-of-adalimumab-d2e7-for-prevention-of-joint-destruction-in-patients-w-102579https://curecurrent.com/trials/evaluation-of-the-role-of-the-autonomic-nervous-system-in-sj-sqrroot-delta-gren-s-syndrome-102580https://curecurrent.com/trials/prednisone-timed-release-tablet-trt-study-modified-release-mr-formulation-of-prednisone-compared-to-standard-immediate-r-102581https://curecurrent.com/trials/the-usability-and-injection-time-of-the-physiolis-syringe-and-autoinjector-in-rheumatoid-arthritis-patients-102582https://curecurrent.com/trials/arthritis-health-journal-proof-of-concept-study-102583https://curecurrent.com/trials/a-study-of-certolizumab-pegol-as-additional-therapy-in-chinese-patients-with-active-rheumatoid-arthritis-102584https://curecurrent.com/trials/an-efficacy-and-safety-study-evaluating-tofacitinib-with-and-without-methotrexate-compared-to-adalimumab-with-methotrexa-102585https://curecurrent.com/trials/andecaliximab-as-add-on-therapy-to-a-tumor-necrosis-factor-inhibitor-and-methotrexate-regimen-in-adults-with-moderately-102586https://curecurrent.com/trials/a-prospective-munti-center-study-on-vanguard-ps-total-knee-replacement-system-102587https://curecurrent.com/trials/vanguard-complete-knee-versus-vanguard-high-flex-rotating-platform-rp-knee-study-102588https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-cam-3001-drug-in-subjects-with-rheumatoid-arthritis-102589https://curecurrent.com/trials/role-of-ultrasound-for-evaluating-rheumatoid-arthritis-in-remission-102590https://curecurrent.com/trials/an-open-label-study-for-participants-with-rheumatoid-arthritis-102591https://curecurrent.com/trials/pmcf-study-for-profemur-am-femoral-components-and-procotyl-o-ha-coated-acetabular-components-102592https://curecurrent.com/trials/neuromusuclar-adaptations-in-the-rheumatoid-arthritis-disease-102593https://curecurrent.com/trials/feasibility-of-an-immersive-virtual-reality-based-biofeedback-intervention-for-outpatients-in-rheumatology-102594https://curecurrent.com/trials/a-study-of-pf-06438179-infliximab-pfizer-and-infliximab-in-combination-with-methotrexate-in-subjects-with-active-rheumat-102595https://curecurrent.com/trials/combination-therapy-of-f8il10-and-methotrexate-in-rheumatoid-arthritis-patients-102596https://curecurrent.com/trials/physical-activity-behavior-of-rheumatoid-arthritis-patients-and-healthy-controls-102597https://curecurrent.com/trials/usability-of-an-ai-for-m923-in-subjects-with-moderate-to-severe-ra-102598https://curecurrent.com/trials/a-study-in-participants-with-rheumatoid-arthritis-102599https://curecurrent.com/trials/long-term-prognosis-and-quality-of-life-in-early-rheumatoid-arthritis-patients-treated-by-2015-acr-guideline-leland-102600https://curecurrent.com/trials/an-observational-study-to-evaluate-the-clinical-effectiveness-quality-of-life-safety-and-tolerability-of-tocilizumab-tcz-102601https://curecurrent.com/trials/u-act-after-an-observational-study-on-long-term-efficacy-of-tight-control-roactemra-actemra-tocilizumab-and-or-methotrex-102602https://curecurrent.com/trials/bone-resorption-osteoclastogenesis-and-adalimumab-102603https://curecurrent.com/trials/radar1-trial-of-a-new-blood-sample-method-remote-arthritis-disease-activity-monitor-102604https://curecurrent.com/trials/a-rheumatoid-arthritis-study-in-participants-on-a-background-treatment-of-methotrexate-102605https://curecurrent.com/trials/echo-systemic-sclerosis-102606https://curecurrent.com/trials/effect-of-periodontal-care-on-rhematoid-arthritis-in-uganda-102607https://curecurrent.com/trials/evaluation-of-tabalumab-using-auto-injector-or-prefilled-syringe-in-participants-with-rheumatoid-arthritis-ra-102608https://curecurrent.com/trials/a-study-of-ly2127399-in-rheumatoid-arthritis-102609https://curecurrent.com/trials/a-rheumatoid-arthritis-study-in-participants-102610https://curecurrent.com/trials/an-open-label-extension-study-in-participants-with-rheumatoid-arthritis-102611https://curecurrent.com/trials/doppler-evaluation-in-ra-patients-after-adalimumab-102612https://curecurrent.com/trials/alloimmune-response-to-citrullinated-shared-epitope-sequence-in-patients-with-rheumatoid-arthritis-102613https://curecurrent.com/trials/predicting-hospitalized-infection-in-patients-with-chronic-inflammatory-arthritis-treated-with-biological-drugs-102614https://curecurrent.com/trials/a-prospective-randomized-double-blind-placebo-controlled-parallel-group-multicentre-phase-iii-study-to-evaluate-the-effi-102615https://curecurrent.com/trials/health-beliefs-and-health-behaviors-among-minorities-with-rheumatic-diseases-102616https://curecurrent.com/trials/a-phase-iii-study-to-evaluate-the-efficacy-and-safety-of-enia11-in-combination-with-methotrexate-versus-methotrexate-alo-102617https://curecurrent.com/trials/a-study-of-subcutaneous-sc-tocilizumab-roactemra-actemra-in-participants-with-active-rheumatoid-arthritis-ra-and-inadequ-102618https://curecurrent.com/trials/study-of-subtalar-arthrodesis-using-allostem-versus-autologous-bone-graft-102619https://curecurrent.com/trials/growth-hormone-in-children-with-juvenile-rheumatoid-arthritis-jra-and-with-crohn-s-disease-102620https://curecurrent.com/trials/peer-to-peer-mentoring-for-individuals-with-early-inflammatory-arthritis-an-effectiveness-study-pilot-rct-peer-mentoring-102621https://curecurrent.com/trials/peer-to-peer-mentoring-for-individuals-with-early-inflammatory-arthritis-an-effectiveness-study-pilot-rct-peer-mentor-tr-102622https://curecurrent.com/trials/a-study-to-assess-immune-response-following-zoster-vaccination-to-subjects-with-rheumatoid-arthritis-receiving-tofacitin-102623https://curecurrent.com/trials/effect-of-andosan-in-patients-with-rheumatoid-arthritis-102624https://curecurrent.com/trials/examination-of-the-effectiveness-of-diffusion-weighted-magnetic-resonance-imaging-for-identifying-poor-prognosis-in-pati-102625https://curecurrent.com/trials/comparing-the-effectiveness-and-safety-of-2-doses-of-an-experimental-drug-cp-690-550-to-methotrexate-mtx-in-patients-wit-102626https://curecurrent.com/trials/a-clinical-trial-study-of-hip-system-in-primary-total-hip-arthroplasty-in-china-102627https://curecurrent.com/trials/a-multicenter-postmarketing-study-evaluating-the-concentration-of-cimzia-in-mature-breast-milk-of-lactating-mothers-102628https://curecurrent.com/trials/a-study-of-tocilizumab-plus-non-biological-dmard-in-patients-with-moderate-to-severe-rheumatoid-arthritis-and-an-inadequ-102629https://curecurrent.com/trials/oral-cf101-tablets-and-methotrexate-treatment-in-rheumatoid-arthritis-patients-102630https://curecurrent.com/trials/milnacipran-for-treatment-of-pain-in-older-adults-with-rheumatoid-arthritis-102631https://curecurrent.com/trials/a-study-of-tocilizumab-added-to-dmards-in-patients-with-moderate-to-severe-rheumatoid-arthritis-and-an-inadequate-respon-102632https://curecurrent.com/trials/treatment-adherence-to-injectable-methotrexate-in-rheumatoid-arthritis-102633https://curecurrent.com/trials/a-study-of-cnto-136-sirukumab-a-human-anti-il-6-monoclonal-antibody-administered-subcutaneously-in-patients-with-active-102634https://curecurrent.com/trials/investigating-the-utilisation-and-effectiveness-of-originator-and-biosimilar-anti-tnf-agents-102635https://curecurrent.com/trials/a-prospective-non-interventional-study-of-roactemra-actemra-tocilizumab-in-patients-with-moderate-to-severe-active-rheum-102636https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-a-single-oral-dose-of-ski-o-703-in-healthy-volunteers-102637https://curecurrent.com/trials/a-phase-iv-study-to-evaluate-the-effect-of-subcutaneous-sc-tocilizumab-administered-to-participants-with-rheumatoid-arth-102638https://curecurrent.com/trials/pharmacogenomic-in-colombian-patients-with-rheumatoid-arthritis-102639https://curecurrent.com/trials/learning-about-biologics-rheumatoid-arthritis-102640https://curecurrent.com/trials/sj-gren-s-syndrome-is-associated-with-meibomian-gland-dysfunction-102641https://curecurrent.com/trials/evolution-of-adipokines-and-body-composition-in-rheumatoid-arthritis-patients-receiving-tocilizumab-therapy-102642https://curecurrent.com/trials/long-term-observational-study-to-evaluation-the-safety-of-furestem-ra-inj-102643https://curecurrent.com/trials/a-long-term-extension-study-to-wa19926-nct01007435-of-tocilizumab-in-participants-with-early-moderate-to-severe-rheumato-102644https://curecurrent.com/trials/impact-and-use-of-abatacept-iv-for-rheumatoid-arthritis-in-real-life-setting-102645https://curecurrent.com/trials/a-study-assessing-the-safety-and-efficacy-of-sarilumab-added-to-non-mtx-dmards-or-as-monotherapy-in-japanese-patients-wi-102646https://curecurrent.com/trials/a-study-assessing-the-efficacy-and-safety-of-sarilumab-added-to-mtx-in-japanese-patients-with-moderately-to-severely-act-102647https://curecurrent.com/trials/evaluating-etanercept-use-in-patients-with-moderate-to-severe-rheumatoid-arthritis-who-have-lost-response-to-adalimumab-102648https://curecurrent.com/trials/efficacy-pharmacokinetics-and-safety-of-bi-695500-in-patients-with-rheumatoid-arthritis-102649https://curecurrent.com/trials/a-study-of-subcutaneous-roactemra-actemra-tocilizumab-as-monotherapy-or-in-combination-with-methotrexate-or-other-non-bi-102650https://curecurrent.com/trials/metabolome-analysis-in-patients-with-rheumatoid-arthritis-102651https://curecurrent.com/trials/clinical-trial-to-evaluate-efficacy-and-safety-of-acellbia-jsc-biocad-with-methotrexate-in-first-line-biological-therapy-102652https://curecurrent.com/trials/gp2013-in-the-treatment-of-ra-patients-refractory-to-or-intolerant-of-standard-therapy-102653https://curecurrent.com/trials/a-study-of-effectiveness-and-safety-of-cnto-136-in-patients-with-active-rheumatoid-arthritis-despite-methotrexate-therap-102654https://curecurrent.com/trials/long-term-efficacy-safety-and-immunogenicity-of-enerceptan-in-rheumatoid-arthritis-gemene002-102655https://curecurrent.com/trials/a-longitudinal-observational-biomarker-study-in-participants-with-primary-sjogren-s-syndrome-102656https://curecurrent.com/trials/bi-695501-compared-to-adalimumab-in-patients-with-active-rheumatoid-arthritis-102657https://curecurrent.com/trials/safety-and-efficacy-of-bi-695500-in-patients-with-moderately-to-severely-active-rheumatoid-arthritis-102658https://curecurrent.com/trials/the-effect-of-puerarin-injection-on-carotid-intima-media-thickness-in-patients-with-rheumatoid-arthritis-102659https://curecurrent.com/trials/a-study-of-cnto-136-sirukumab-administered-subcutaneously-in-patients-with-active-rheumatoid-arthritis-despite-disease-m-102660https://curecurrent.com/trials/periodontal-inflammation-and-immunity-in-preclinical-rheumatoid-arthritis-102661https://curecurrent.com/trials/a-study-of-bms-986195-in-healthy-male-subjects-102662https://curecurrent.com/trials/blood-sample-collection-study-for-pharmacogenomic-characterization-of-participants-that-previously-received-namilumab-in-102663https://curecurrent.com/trials/multicenter-post-marketing-non-interventional-observational-study-in-ra-patients-treated-with-roactemra-actemra-tocilizu-102664https://curecurrent.com/trials/gp2013-treatment-in-patients-with-active-rheumatoid-arthritis-previously-treated-with-rituxan-or-mabthera-102665https://curecurrent.com/trials/a-trial-with-humanized-tnf-monoclonal-antibody-injection-by-single-dose-and-dose-escalation-in-healthy-subjects-102666https://curecurrent.com/trials/a-study-of-the-impact-of-methotrexate-mtx-discontinuation-on-the-efficacy-of-subcutaneous-sc-tocilizumab-tcz-with-mtx-102667https://curecurrent.com/trials/home-monitoring-of-patients-with-rheumatoid-arthritis-an-ehealth-development-study-102668https://curecurrent.com/trials/al-2-mp-1-polyimide-acetabular-liner-102669https://curecurrent.com/trials/effects-of-concomitant-administration-of-bms-986195-on-methotrexate-caffeine-montelukast-flurbiprofen-omeprazole-midazol-102670https://curecurrent.com/trials/the-effect-of-certolizumab-pegol-on-mri-synovitis-and-bone-edema-in-rheumatoid-arthritis-patients-102671https://curecurrent.com/trials/remission-in-rheumatoid-arthritis-in-the-asian-pacific-region-102672https://curecurrent.com/trials/long-term-efficacy-and-safety-of-repeated-ofatumumab-treatment-courses-in-ra-patients-who-previously-received-ofatumumab-102673https://curecurrent.com/trials/a-study-to-assess-inflammation-in-rheumatoid-arthritis-using-molecular-imaging-techniques-102674https://curecurrent.com/trials/sleep-and-immunity-in-rheumatoid-arthritis-remicade-substudy-102675https://curecurrent.com/trials/a-study-to-compare-fkb327-efficacy-and-safety-with-humira-in-rheumatoid-arthritis-patients-102676https://curecurrent.com/trials/evolution-of-total-energy-expenditure-and-its-various-components-in-active-rheumatoid-arthritis-ra-treated-with-anti-tnf-102677https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-multiple-subcutaneous-injections-of-abt-122-in-subje-102678https://curecurrent.com/trials/a-study-in-healthy-adults-and-adult-subjects-with-rheumatoid-arthritis-to-evaluate-the-safety-tolerability-and-pharmacok-102679https://curecurrent.com/trials/is-ultrasound-remission-a-real-remission-does-ultrasound-permit-to-achieve-and-maintain-the-remission-in-rheumatoid-arth-102680https://curecurrent.com/trials/pharmacokinetic-and-safety-study-with-adalimumab-in-chinese-subjects-with-mild-rheumatoid-arthritis-102681https://curecurrent.com/trials/project-jay-tha-registration-study-102682https://curecurrent.com/trials/tc-a-registration-study-102683https://curecurrent.com/trials/a-specification-clinical-application-research-of-tripterygium-wilfordii-treating-rheumatoid-arthritis-102684https://curecurrent.com/trials/investigating-clinical-efficacy-of-ofatumumab-in-adult-rheumatoid-arthritis-ra-patients-who-had-an-inadequate-response-t-102685https://curecurrent.com/trials/efficacy-safety-and-immunogenicity-of-enerceptan-compared-to-enbrel-in-rheumatoid-arthritis-102686https://curecurrent.com/trials/real-world-clinical-efficacy-of-abatacept-in-the-t3-data-registry-102687https://curecurrent.com/trials/biomarkers-of-remission-in-rheumatoid-arthritis-biorra-102688https://curecurrent.com/trials/efficacy-and-safety-of-twhf-and-mtx-in-patients-with-rheumatoid-arthritis-102689https://curecurrent.com/trials/a-study-comparing-sirukumab-cnto-136-monotherapy-with-adalimumab-humira-monotherapy-in-the-treatment-of-active-rheumatoi-102690https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-multiple-ascending-doses-of-ski-o-703-in-healthy-volunteers-102691https://curecurrent.com/trials/anti-cd20-antibody-therapy-for-sjogren-s-syndrome-102692https://curecurrent.com/trials/the-effect-of-adalimumab-plus-methotrexate-mtx-versus-placebo-plus-mtx-on-cartilage-in-ra-patients-102693https://curecurrent.com/trials/an-multicentre-clinical-study-to-evaluate-the-usability-and-safety-of-the-autoinjector-and-pre-filled-syringe-of-sb4-in-102694https://curecurrent.com/trials/genetics-of-rheumatoid-arthritis-102695https://curecurrent.com/trials/comparison-of-compliance-and-evolution-of-functional-capacity-of-patients-with-rheumatoid-arthritis-treated-by-methotrex-102696https://curecurrent.com/trials/cell-phone-based-automated-monitoring-of-patients-with-early-rheumatoid-arthritis-102697https://curecurrent.com/trials/health-outcomes-in-rheumatoid-arthritis-102698https://curecurrent.com/trials/red-yeast-rice-and-subclinical-atherosclerosis-in-patients-with-rheumatoid-arthritis-102699https://curecurrent.com/trials/role-of-hydroxychloroquine-to-improve-endothelial-dysfunction-in-patients-with-rheumatoid-arthritis-102700https://curecurrent.com/trials/a-pharmacokinetic-pk-and-pharmacodynamic-pd-study-of-golimumab-in-patients-with-rheumatoid-arthritis-ra-102701https://curecurrent.com/trials/the-nor-switch-study-102702https://curecurrent.com/trials/hand-exercises-for-women-with-rheumatoid-arthritis-and-impaired-adl-ability-an-exploratory-trial-102703https://curecurrent.com/trials/effects-of-probiotics-on-rheumatoid-arthritis-patients-102704https://curecurrent.com/trials/a-study-comparing-sb2-to-remicade-in-subjects-with-moderate-to-severe-rheumatoid-arthritis-despite-methotrexate-therapy-102705https://curecurrent.com/trials/excia-t-cementless-ebra-study-102706https://curecurrent.com/trials/factors-affecting-hand-dysfunction-in-patient-with-rheumatoid-arthritis-and-its-correlation-with-quality-of-life-102707https://curecurrent.com/trials/long-term-safety-and-efficacy-of-furestem-cd-inj-in-patients-with-moderately-active-crohn-s-disease-cd-102708https://curecurrent.com/trials/effect-of-sar153191-regn88-with-methotrexate-in-patients-with-active-rheumatoid-arthritis-who-failed-tnf-blockers-102709https://curecurrent.com/trials/t-cell-subsets-in-rheumatoid-arthritis-patients-on-long-term-anti-tnf-or-il6-receptor-blocker-therapy-102710https://curecurrent.com/trials/clue-study-connective-tissue-disease-leg-ulcer-etiology-study-102711https://curecurrent.com/trials/diagnostic-value-of-anti-mcv-in-pts-with-ra-102712https://curecurrent.com/trials/validation-of-the-french-version-of-the-health-assessment-questionnaire-ii-haq-ii-for-rheumatoid-arthritis-102713https://curecurrent.com/trials/study-to-investigate-the-safety-and-efficacy-of-tregalizumab-in-subjects-mtx-ir-with-active-rheumatoid-arthritis-102714https://curecurrent.com/trials/protocol-for-the-quantitation-of-pain-in-the-diagnosis-of-polymyalgia-rheumatica-102715https://curecurrent.com/trials/study-of-people-with-rheumatoid-arthritis-who-require-joint-surgery-in-the-hand-102716https://curecurrent.com/trials/a-study-of-mabthera-rituxan-rituximab-in-combination-with-methotrexate-in-patients-with-rheumatoid-arthritis-and-inadequ-102717https://curecurrent.com/trials/a-study-with-tocilizumab-roactemra-actemra-monotherapy-or-in-combination-with-methotrexate-in-patients-with-rheumatoid-a-102718https://curecurrent.com/trials/a-study-of-re-treatment-with-mabthera-rituximab-in-patients-with-rheumatoid-arthritis-who-have-had-an-inadequate-respons-102719https://curecurrent.com/trials/a-study-comparing-sb5-to-humira-in-subjects-with-moderate-to-severe-rheumatoid-arthritis-despite-methotrexate-therapy-102720https://curecurrent.com/trials/a-study-comparing-sb4-to-enbrel-in-subjects-with-moderate-to-severe-rheumatoid-arthritis-despite-methotrexate-therapy-102721https://curecurrent.com/trials/a-study-of-mabthera-rituximab-in-patients-with-rheumatoid-arthritis-and-an-inadequate-response-to-methotrexate-102722https://curecurrent.com/trials/a-study-of-roactemra-actemra-tocilizumab-in-patients-with-rheumatoid-arthritis-who-have-an-inadequate-response-to-dmards-102723https://curecurrent.com/trials/a-pilot-study-of-mabthera-rituximab-evaluated-by-mri-in-patients-with-rheumatoid-arthritis-102724https://curecurrent.com/trials/a-phase-i-rheumatoid-arthritis-study-in-healthy-volunteers-102725https://curecurrent.com/trials/open-label-study-to-assess-the-predictability-of-early-response-to-certolizumab-pegol-in-patients-with-rheumatoid-arthri-102726https://curecurrent.com/trials/a-study-of-mabthera-rituximab-in-patients-with-rheumatoid-arthritis-who-have-failed-on-one-prior-anti-tnf-therapy-reset-102727https://curecurrent.com/trials/a-study-of-mabthera-rituximab-in-participants-with-rheumatoid-arthritis-who-have-had-an-inadequate-response-to-disease-m-102728https://curecurrent.com/trials/kineret-in-the-treatment-of-rheumatoid-arthritis-102729https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-rituximab-on-immune-responses-in-subjects-with-active-rheumatoid-arthritis-receiving-102730https://curecurrent.com/trials/autologous-adipose-tissue-stromal-vascular-fraction-cells-for-rheumatoid-arthritis-102731https://curecurrent.com/trials/examining-the-immunological-process-of-autoimmune-patients-102732https://curecurrent.com/trials/to-evaluate-the-effect-of-sar153191-regn88-added-to-other-ra-drugs-in-patients-with-ra-who-are-not-responding-to-or-into-102733https://curecurrent.com/trials/activity-and-safety-of-oral-administration-of-ssr150106xb-for-the-reduction-of-inflammation-in-patients-with-active-rheu-102734https://curecurrent.com/trials/a-clinical-investigation-of-the-discovery-elbow-system-102735https://curecurrent.com/trials/a-study-to-assess-the-effect-of-tocilizumab-on-signs-and-symptoms-in-patients-with-rheumatoid-arthritis-102736https://curecurrent.com/trials/laser-therapy-to-treat-the-dry-mouth-of-sjogren-s-syndrome-102737https://curecurrent.com/trials/a-study-of-tocilizumab-in-patients-with-rheumatoid-arthritis-who-have-an-inadequate-response-to-current-non-biologic-dma-102738https://curecurrent.com/trials/a-study-of-tocilizumab-dmards-in-patients-with-moderate-to-severe-active-rheumatoid-arthritis-102739https://curecurrent.com/trials/study-to-evaluate-the-safety-tolerability-and-efficacy-of-tocilizumab-in-participants-with-rheumatoid-arthritis-ra-who-h-102740https://curecurrent.com/trials/an-observational-study-to-describe-in-routine-clinical-practice-the-treatment-patterns-of-usage-of-biological-dmards-in-102741https://curecurrent.com/trials/toscara-study-a-study-of-subcutaneous-tocilizumab-roactemra-actemra-in-participants-with-active-rheumatoid-arthritis-na-102742https://curecurrent.com/trials/an-observational-study-of-tocilizumab-actemra-in-participants-with-moderate-to-severe-rheumatoid-arthritis-102743https://curecurrent.com/trials/a-study-on-the-safety-of-administering-rituximab-at-a-more-rapid-rate-in-patients-with-rheumatoid-arthritis-102744https://curecurrent.com/trials/effect-assessment-of-periodontal-prophylaxis-on-rheumatoid-arthritis-activity-102745https://curecurrent.com/trials/an-extension-study-to-demonstrate-long-term-efficacy-and-safety-of-ct-p13-when-co-administered-with-methotrexate-in-pati-102746https://curecurrent.com/trials/a-study-of-tocilizumab-in-combination-with-dmard-therapy-in-patients-with-active-rheumatoid-arthritis-102747https://curecurrent.com/trials/use-of-thermal-and-3d-imaging-to-quantify-arthritis-102748https://curecurrent.com/trials/a-single-dose-of-compound-sb-681323-compared-to-prednisolone-on-a-protein-that-is-an-indicator-for-rheumatoid-arthritis-102749https://curecurrent.com/trials/efficacy-and-safety-study-of-cc-292-versus-placebo-as-co-therapy-with-methotrexate-in-active-rheumatoid-arthritis-102750https://curecurrent.com/trials/a-study-to-evaluate-rituximab-in-combination-with-methotrexate-in-methotrexate-naive-patients-with-active-rheumatoid-art-102751https://curecurrent.com/trials/cementless-alumina-alumina-total-hip-and-hybrid-102752https://curecurrent.com/trials/pharmacist-cvd-intervention-for-patients-with-inflammatory-arthritis-102753https://curecurrent.com/trials/an-evaluation-of-sarilumab-plus-methotrexate-compared-to-etanercept-plus-methotrexate-in-ra-patients-not-responding-to-a-102754https://curecurrent.com/trials/a-study-of-the-effect-of-tocilizumab-on-markers-of-atherogenic-risk-in-patients-with-moderate-to-severe-rheumatoid-arthr-102755https://curecurrent.com/trials/prevention-of-arthritis-related-work-disability-102756https://curecurrent.com/trials/a-study-of-tocilizumab-as-monotherapy-and-in-combination-with-methotrexate-versus-methotrexate-in-patients-with-early-mo-102757https://curecurrent.com/trials/phase-2-multicenter-open-label-extension-study-with-abt-122-in-rheumatoid-arthritis-subjects-who-have-completed-the-prec-102758https://curecurrent.com/trials/diagnostic-utility-of-anti-mcv-antibodies-anti-ccpantibodies-and-rf-in-ra-102759https://curecurrent.com/trials/this-study-is-randomised-single-oral-dose-bioequivalence-study-of-meloxicam-gsk-15-mg-tablets-102760https://curecurrent.com/trials/maxim-knee-pop-top-tibia-vs-regular-maxim-knee-tibia-102761https://curecurrent.com/trials/the-comparative-study-of-intra-articular-injection-of-tocilizumab-and-compound-betamethasone-102762https://curecurrent.com/trials/a-study-to-evaluate-tocilizumab-treatment-in-a-real-life-setting-102763https://curecurrent.com/trials/a-study-of-tocilizumab-in-comparison-to-etanercept-in-participants-with-rheumatoid-arthritis-and-cardiovascular-disease-102764https://curecurrent.com/trials/a-study-to-evaluate-efficacy-of-tocilizumab-administered-as-monotherapy-or-in-combination-with-methotrexate-and-or-other-102765https://curecurrent.com/trials/identification-of-genes-associated-with-lung-disease-in-patients-with-rheumatoid-arthritis-102766https://curecurrent.com/trials/specimen-collection-for-individuals-with-lung-disease-associated-with-rheumatoid-arthritis-102767https://curecurrent.com/trials/evaluation-of-salivary-gland-dysfunction-102768https://curecurrent.com/trials/confirmation-of-systemic-autoimmune-diseases-in-the-agricultural-health-study-102769https://curecurrent.com/trials/supporting-patient-care-with-electronic-resource-super-102770https://curecurrent.com/trials/a-multi-centre-study-to-assess-the-long-term-performance-of-the-pinnacle-cup-with-a-polyethylene-on-metal-bearing-in-pri-102771https://curecurrent.com/trials/evaluation-of-sarilumab-sar153191-regn88-on-top-of-methotrexate-in-rheumatoid-arthritis-patients-102772https://curecurrent.com/trials/an-electronic-data-capture-study-to-assess-the-long-term-performance-of-the-depuy-proxima-hip-in-primary-total-hip-repla-102773https://curecurrent.com/trials/a-multi-centre-study-to-assess-the-long-term-performance-of-the-depuy-proxima-hip-in-primary-total-hip-replacement-102774https://curecurrent.com/trials/a-multi-centre-study-to-assess-the-long-term-performance-of-the-depuy-asr-system-in-primary-hip-resurfacing-surgery-102775https://curecurrent.com/trials/study-to-evaluate-sc-route-of-administration-of-ofatumumab-in-ra-patients-102776https://curecurrent.com/trials/a-two-centre-study-to-assess-the-stability-and-long-term-performance-of-the-c-stem-amt-in-a-total-primary-hip-replacemen-102777https://curecurrent.com/trials/to-evaluate-the-safety-of-sar153191-regn88-and-tocilizumab-added-to-other-ra-drugs-in-patients-with-ra-who-are-not-respo-102778https://curecurrent.com/trials/a-single-centre-study-to-assess-the-long-term-performance-of-the-depuy-asr-system-in-primary-hip-resurfacing-surgery-102779https://curecurrent.com/trials/observational-study-to-explore-the-effectiveness-of-adalimumab-treatment-in-conjunction-with-utilization-of-a-patient-su-102780https://curecurrent.com/trials/an-mri-guided-treatment-strategy-to-prevent-disease-progression-in-patients-with-rheumatoid-arthritis-102781https://curecurrent.com/trials/a-clinical-investigation-of-the-copeland-humeral-resurfacing-head-102782https://curecurrent.com/trials/a-clinical-investigation-of-the-comprehensive-biomodular-and-bi-angular-shoulder-systems-102783https://curecurrent.com/trials/a-clinical-investigation-of-recovery-following-hip-resurfacing-or-total-hip-arthroplasty-102784https://curecurrent.com/trials/i-beam-and-cruciate-tibial-components-used-in-total-knee-replacement-102785https://curecurrent.com/trials/total-knee-replacement-using-simplex-or-cobalt-bone-cement-102786https://curecurrent.com/trials/a-clinical-investigation-of-the-m2a-magnum-hip-system-102787https://curecurrent.com/trials/a-clinical-investigation-of-the-balance-microplasty-hip-system-102788https://curecurrent.com/trials/a-clinical-investigation-of-the-taperloc-microplasty-hip-system-102789https://curecurrent.com/trials/total-knee-replacement-with-duracon-and-vanguard-prostheses-102790https://curecurrent.com/trials/to-evaluate-the-immunogenicity-and-safety-of-sarilumab-administered-as-monotherapy-in-patients-with-rheumatoid-arthritis-102791https://curecurrent.com/trials/effects-of-denosumab-on-the-pharmacokinetics-of-etanercept-102792https://curecurrent.com/trials/to-evaluate-sarilumab-sar153191-regn88-auto-injector-device-in-patients-with-rheumatoid-arthritis-102793https://curecurrent.com/trials/a-study-of-tocilizumab-in-combination-with-disease-modifying-anti-rheumatic-drugs-dmards-in-participants-with-moderate-t-102794https://curecurrent.com/trials/relationship-of-ywhah-polymorphisms-to-rheumatoid-arthritis-disease-severity-102795https://curecurrent.com/trials/a-clinical-evaluation-of-metal-ion-release-from-metal-on-metal-cementless-total-hip-arthroplasty-102796https://curecurrent.com/trials/a-study-on-safety-and-efficacy-of-tocilizumab-roactemra-actemra-alone-or-in-combination-with-non-biologic-antirheumatics-102797https://curecurrent.com/trials/a-study-in-participants-with-rheumatoid-arthritis-on-background-methotrexate-therapy-102798https://curecurrent.com/trials/assessment-of-the-effectiveness-of-iv-and-sc-abatacept-orencia-patient-alert-cards-in-patients-with-rheumatoid-arthritis-102799https://curecurrent.com/trials/gene-expression-profiling-in-pbmcs-as-a-tool-for-prediction-of-anakinra-responsiveness-in-rheumatoid-arthritis-102800https://curecurrent.com/trials/a-long-term-safety-extension-study-of-tocilizumab-in-brazilian-participants-with-rheumatoid-arthritis-ra-who-completed-t-102801https://curecurrent.com/trials/safety-pharmacodynamics-and-pharmacokinetics-of-gsk2136525-repeat-dose-in-rheumatoid-arthritis-102802https://curecurrent.com/trials/study-to-evaluate-the-long-term-safety-of-hydrocodone-bitartrate-extended-release-tablets-cep-33237-in-patients-who-requ-102803https://curecurrent.com/trials/hydroxytriptolide-in-active-rheumatoid-arthritis-patients-with-an-inadequate-response-to-methotrexate-102804https://curecurrent.com/trials/reduction-of-daily-sitting-time-in-patients-with-rheumatoid-arthritis-102805https://curecurrent.com/trials/a-long-term-safety-study-of-mavrilimumab-in-adult-subjects-with-rheumatoid-arthritis-102806https://curecurrent.com/trials/multiple-dose-study-of-ucb4940-as-add-on-to-certolizumab-pegol-in-subjects-with-rheumatoid-arthritis-102807https://curecurrent.com/trials/study-of-90mg-of-gw274150-in-subjects-over-50-years-who-have-rheumatoid-arthritis-ra-102808https://curecurrent.com/trials/a-study-of-rofecoxib-versus-naproxen-in-the-treatment-of-chinese-patient-with-rheumatoid-arthritis-0966-231-102809https://curecurrent.com/trials/injections-of-flograft-therapy-autologous-stem-cells-or-platelet-rich-plasma-for-the-treatment-of-degenerative-joint-pai-102810https://curecurrent.com/trials/gotnet-study-the-gothenburg-nurse-led-tight-control-study-102811https://curecurrent.com/trials/tocilizumab-effect-on-microrna-expression-and-adipokine-levels-in-rheumatoid-arthritis-patients-102812https://curecurrent.com/trials/is-sj-gren-s-syndrome-associated-with-meibomian-gland-dysfunction-102813https://curecurrent.com/trials/abatacept-post-marketing-clinical-study-in-japan-102814https://curecurrent.com/trials/study-to-assess-the-immunogenicity-safety-and-efficacy-of-high-capacity-process-etanercept-in-rheumatoid-arthritis-subje-102815https://curecurrent.com/trials/single-patient-use-of-tocilizumab-in-systemic-onset-juvenile-idiopathic-arthritis-102816https://curecurrent.com/trials/phase-1-dose-escalating-study-to-assess-safety-tolerability-food-effect-and-pk-of-chr-5154-in-healthy-male-volunteers-102817https://curecurrent.com/trials/endoscopic-treatment-of-salivary-glands-affected-by-sj-gren-s-syndrome-102818https://curecurrent.com/trials/description-of-joint-population-and-assessment-of-impact-on-health-status-of-orencia-in-patients-with-rheumatoid-arthrit-102819https://curecurrent.com/trials/a-study-to-evaluate-the-effectiveness-of-infliximab-and-changes-in-hand-and-wrist-magnetic-resonance-imaging-mri-in-part-102820https://curecurrent.com/trials/dental-prophylaxis-and-rheumatoid-arthritis-102821https://curecurrent.com/trials/causes-of-comorbid-infertility-among-women-with-rheumatoid-arthritis-102822https://curecurrent.com/trials/walk-for-rheumatoid-arthritis-wara-study-102823https://curecurrent.com/trials/efficacy-and-safety-study-of-r935788-tablets-to-treat-rheumatoid-arthritis-taski-3-102824https://curecurrent.com/trials/difference-in-gc-induced-adrenal-insufficiency-in-ra-related-to-polymorphisms-in-the-glucocorticoid-receptor-gene-102825https://curecurrent.com/trials/topical-compound-tripterygium-wilfordii-hook-f-for-patients-with-active-rheumatoid-arthritis-102826https://curecurrent.com/trials/a-study-of-imatinib-400-mg-once-daily-in-combination-with-methotrexate-in-the-treatment-of-rheumatoid-arthritis-102827https://curecurrent.com/trials/screening-protein-markers-in-patients-with-rheumatoid-arthritis-and-hot-dampness-and-blood-stasis-syndrome-102828https://curecurrent.com/trials/post-marketing-study-assessing-the-long-term-safety-of-abatacept-102829https://curecurrent.com/trials/is-fluidotherapy-effective-in-rheumatoid-hand-102830https://curecurrent.com/trials/gamma-vacuum-foil-gvf-versus-cross-linked-polyethylene-in-total-knee-arthroplasty-study-102831https://curecurrent.com/trials/long-term-safety-and-efficacy-of-abp-501-in-subjects-with-moderate-to-severe-rheumatoid-arthritis-102832https://curecurrent.com/trials/fibrocytes-in-rheumatoid-arthritis-asthma-and-interstitial-lung-disease-102833https://curecurrent.com/trials/a-relative-bioavailability-and-food-effect-study-of-new-formulations-102834https://curecurrent.com/trials/ultrasound-utility-in-routine-clinical-practise-102835https://curecurrent.com/trials/study-of-pharmacodynamic-effects-of-vay736-in-patients-with-primary-sj-gren-s-syndrome-102836https://curecurrent.com/trials/long-term-experience-with-abatacept-in-routine-clinical-practice-102837https://curecurrent.com/trials/reduced-ultrasound-counts-in-rheumatoid-arthritis-102838https://curecurrent.com/trials/robotic-arm-assisted-total-knee-arthroplasty-102839https://curecurrent.com/trials/a-study-of-the-safety-of-rituximab-in-combination-with-other-anti-rheumatic-drugs-in-subjects-with-active-rheumatoid-art-102840https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-rituximab-in-combination-with-methotrexate-compared-to-methotrexate-alone-102841https://curecurrent.com/trials/subcutaneous-golimumab-glm-plus-dmards-for-rheumatoid-arthritis-followed-by-intravenous-subcutaneous-glm-strategy-p06129-102842https://curecurrent.com/trials/a-trial-of-anti-tnf-chimeric-monoclonal-antibody-ca2-in-korean-patients-with-active-rheumatoid-arthritis-despite-methore-102843https://curecurrent.com/trials/cimzia-treatment-in-rheumatoid-arthritis-randomizing-to-stop-versus-continue-disease-modifying-anti-rheumatic-drug-s-102844https://curecurrent.com/trials/special-investigation-in-patients-with-rheumatoid-arthritis-working-productivity-activity-impairment-102845https://curecurrent.com/trials/the-durability-of-early-ra-disease-control-after-tocilizumab-withdrawal-a-canadian-experience-102846https://curecurrent.com/trials/induction-of-remission-in-ra-patients-at-low-disease-activity-by-additional-infliximab-therapy-study-p04644am1-terminate-102847https://curecurrent.com/trials/a-golimumab-phase-3b-multicenter-assessment-of-intravenous-efficacy-in-rheumatoid-arthritis-subjects-who-have-diminished-102848https://curecurrent.com/trials/alendronate-osteoporosis-study-102849https://curecurrent.com/trials/re-re-cube-retain-remicade-response-study-p04249am3-102850https://curecurrent.com/trials/teriparatide-for-joint-erosions-in-rheumatoid-arthritis-the-tera-trial-102851https://curecurrent.com/trials/68ga-bnota-prgd2-pet-ct-in-patients-with-rheumatoid-arthritis-102852https://curecurrent.com/trials/a-clinical-trial-for-ctd-ild-treatment-102853https://curecurrent.com/trials/cognitive-behavioral-treatment-for-rheumatoid-arthritis-102854https://curecurrent.com/trials/puerarin-versus-atorvastatin-in-treating-metabolism-syndrome-in-patients-with-chronic-rheumatic-diseases-102855https://curecurrent.com/trials/the-effect-of-square-dance-on-rheumatoid-arthritis-102856https://curecurrent.com/trials/qingkailing-injection-versus-puerarin-injection-on-withdrawal-rate-of-corticosteroids-in-patients-with-active-rheumatoid-102857https://curecurrent.com/trials/efficacy-at-24-weeks-and-safety-tolerability-and-long-term-efficacy-up-to-2-years-of-secukinumab-ain457-in-patients-with-102858https://curecurrent.com/trials/single-dose-study-to-assess-efficacy-of-canakinumab-acz885-in-patients-with-active-juvenile-idiopathic-arthritis-sjia-102859https://curecurrent.com/trials/to-demonstrate-the-relative-bioavailability-parallel-study-of-leflunomide-20-mg-tablets-under-fasting-conditions-102860https://curecurrent.com/trials/efficacy-of-remicade-in-the-treatment-of-active-rheumatoid-arthritis-despite-methotrexate-study-p03027-102861https://curecurrent.com/trials/relative-bioavailability-study-of-naproxen-delayed-release-tablets-375-mg-102862https://curecurrent.com/trials/safety-and-tolerability-study-of-mbs2320-in-healthy-subjects-and-subjects-with-rheumatoid-arthritis-102863https://curecurrent.com/trials/evaluate-effects-of-personalized-patient-counselling-for-enbrel-therapy-in-adults-with-rheumatoid-arthritis-102864https://curecurrent.com/trials/study-of-safety-and-efficacy-of-bcd-020-comparing-to-mabthera-in-patients-with-rheumatoid-arthritis-102865https://curecurrent.com/trials/post-approval-study-to-investigate-the-long-term-8-year-survivorship-of-star-ankle-among-continued-access-study-patients-102866https://curecurrent.com/trials/a-placebo-controlled-double-blinded-randomized-trial-of-remicade-in-korean-patients-with-rheumatoid-arthritis-despite-me-102867https://curecurrent.com/trials/living-well-with-rheumatoid-arthritis-102868https://curecurrent.com/trials/cryotherapy-and-doppler-in-inflammatory-rheumatic-diseases-102869https://curecurrent.com/trials/treatment-of-vitamin-d-deficiency-in-patients-with-rheumatoid-arthritis-102870https://curecurrent.com/trials/efficacy-radiographic-and-laboratory-changes-in-refractory-rheumatoid-arthritis-patients-treated-with-h-p-acthar-gel-102871https://curecurrent.com/trials/prospective-follow-up-of-patients-with-chronic-inflammatory-rheumatism-102872https://curecurrent.com/trials/assessing-the-suitability-of-an-imaging-probe-for-use-in-clinical-cell-and-gene-therapy-trials-in-cancer-and-rheumatoid-102873https://curecurrent.com/trials/cox-2-inhibitor-study-in-patients-with-rheumatoid-arthritis-102874https://curecurrent.com/trials/extension-study-to-assess-the-efficacy-and-safety-of-repeat-treatment-with-rituximab-mabthera-in-participants-with-activ-102875https://curecurrent.com/trials/benefits-of-injectable-abatacept-using-magnetic-resonance-imaging-mri-in-rheumatoid-arthritis-ra-patients-102876https://curecurrent.com/trials/kunxian-for-the-treatment-of-rheumatoid-arthritis-102877https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-a-single-dose-of-cnto-136-sirukumab-on-cyp450-enzyme-activities-after-subcutaneous-adm-102878https://curecurrent.com/trials/workability-in-patients-with-seropositive-rheumatoid-arthritis-102879https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-tocilizumab-in-adults-with-rheumatoid-arthritis-102880https://curecurrent.com/trials/physical-activity-in-patients-with-rheumatoid-arthritis-treated-with-adalimumab-in-routine-clinical-practice-102881https://curecurrent.com/trials/prospective-study-on-intensive-early-rheumatoid-arthritis-treatment-102882https://curecurrent.com/trials/study-of-anti-viral-prophylaxis-for-hbsag-or-hbcab-hbsab-patients-starting-anti-tnf-102883https://curecurrent.com/trials/treatment-of-refractory-adult-onset-still-s-disease-with-anakinra-a-randomized-study-102884https://curecurrent.com/trials/a-study-to-assess-the-long-term-performance-of-smartset-hv-and-smartset-ghv-bone-cements-in-primary-total-hip-replacemen-102885https://curecurrent.com/trials/safety-and-efficacy-of-adipose-derived-stem-cells-in-refractory-rheumatoid-arthritis-systemic-lupus-erythematosus-or-sha-102886https://curecurrent.com/trials/safety-tolerability-pharmacodynamics-and-efficacy-study-of-tab08-in-patients-with-rheumatoid-arthritis-102887https://curecurrent.com/trials/study-evaluating-the-safety-and-efficacy-of-enbrel-etanercept-in-japan-102888https://curecurrent.com/trials/blood-based-eyedrops-from-different-sources-in-the-treatment-of-severe-keratopathy-102889https://curecurrent.com/trials/first-human-dose-trial-of-nnc0215-0384-in-subjects-with-rheumatoid-arthritis-102890https://curecurrent.com/trials/french-national-registry-art-registry-observational-study-102891https://curecurrent.com/trials/a-non-interventional-study-evaluating-rheumatoid-arthritis-participants-treated-with-tocilizumab-roactemra-actemra-102892https://curecurrent.com/trials/etanercept-enbrel-special-investigation-regulatory-post-marketing-commitment-plan-102893https://curecurrent.com/trials/study-to-determine-the-pharmacokinetics-of-sulfasalazine-in-children-with-juvenile-idiopathic-arthritis-102894https://curecurrent.com/trials/inbone-total-ankle-arthroplasty-taa-using-calcaneal-stem-fixation-102895https://curecurrent.com/trials/exercise-training-in-patients-with-rheumatoid-arthritis-and-cryotherapy-102896https://curecurrent.com/trials/registry-for-analysis-of-compliance-in-colombian-participants-with-rheumatoid-arthritis-exposed-to-golimumab-102897https://curecurrent.com/trials/moderate-rheumatoid-arthritis-ra-with-etanercept-enbrel-102898https://curecurrent.com/trials/safety-and-tolerability-of-anti-il-20-in-subjects-with-rheumatoid-arthritis-102899https://curecurrent.com/trials/open-label-extension-treatment-with-etanercept-tnfr-fc-for-participating-patients-in-etanercept-tnfr-fc-clinical-trials-102900https://curecurrent.com/trials/safety-and-tolerability-of-anti-il-20-in-healthy-volunteers-and-patients-with-rheumatoid-arthritis-102901https://curecurrent.com/trials/dose-escalation-trial-of-anti-c5ar-antibody-in-healthy-subjects-102902https://curecurrent.com/trials/efficacy-of-nnc109-0012-in-subjects-with-active-rheumatoid-arthritis-102903https://curecurrent.com/trials/a-multiple-dose-trial-of-nnc-0151-0000-0000-in-subjects-with-rheumatoid-arthritis-102904https://curecurrent.com/trials/effect-of-monoclonal-anti-il6-antibody-tocilizumab-on-the-cardiovascular-risk-in-patients-with-rheumatoid-arthritis-102905https://curecurrent.com/trials/first-in-man-trial-of-nnc114-0005-in-healthy-subjects-and-subjects-with-rheumatoid-arthritis-102906https://curecurrent.com/trials/patient-reported-outcomes-reported-via-pc-tablet-home-versus-touch-screen-at-hospital-among-patients-with-arthritis-102907https://curecurrent.com/trials/safety-and-tolerability-of-nnc0114-0006-at-increasing-dose-levels-in-subjects-with-rheumatoid-arthritis-102908https://curecurrent.com/trials/etanercept-in-rheumatoid-arthritis-and-vascular-inflammation-102909https://curecurrent.com/trials/a-randomised-double-blind-placebo-controlled-parallel-group-trial-to-assess-clinical-efficacy-of-nnc0114-0006-in-subject-102910https://curecurrent.com/trials/ppar-gamma-agonists-rheumatoid-arthritis-and-cardiovascular-disease-102911https://curecurrent.com/trials/investigation-of-avacen-thermal-exchange-system-for-fibromyalgia-pain-102912https://curecurrent.com/trials/the-health-log-a-randomized-clinical-trial-102913https://curecurrent.com/trials/a-long-term-extension-study-of-wa19926-on-the-safety-of-tocilizumab-roactemra-actemra-in-participants-with-early-moderat-102914https://curecurrent.com/trials/an-observational-study-of-mabthera-rituxan-rituximab-and-alternative-tnf-inhibitors-in-patients-with-rheumatoid-arthriti-102915https://curecurrent.com/trials/the-effects-of-a-six-week-exercise-programme-undertaken-by-women-with-rheumatoid-arthritis-102916https://curecurrent.com/trials/bms-188667-in-children-and-adolescents-with-juvenile-rheumatoid-arthritis-102917https://curecurrent.com/trials/study-of-iguratimod-in-sj-gren-s-syndrome-102918https://curecurrent.com/trials/survey-on-long-term-use-of-orencia-intravenous-infusion-250mg-102919https://curecurrent.com/trials/use-results-survey-for-orencia-subcutaneous-injection-125mg-syringe-1ml-102920https://curecurrent.com/trials/an-exploratory-study-of-changes-in-synovial-immune-responses-following-bms-188667-therapy-in-subjects-with-active-rheuma-102921https://curecurrent.com/trials/prospective-study-measuring-clinical-outcomes-of-knee-arthroplasty-using-the-verasense-knee-system-102922https://curecurrent.com/trials/armonia-an-observational-study-of-biologic-drugs-in-monotherapy-or-combination-with-dmards-in-italian-clinical-practice-102923https://curecurrent.com/trials/abatacept-for-patients-with-inflammatory-arthritis-associated-with-sj-gren-s-syndrome-an-open-label-phase-ii-study-102924https://curecurrent.com/trials/duration-of-immune-response-to-influenza-vaccination-in-patients-with-ra-102925https://curecurrent.com/trials/a-feasibility-study-exploring-the-effect-of-remicade-on-the-disease-activity-in-ra-patients-study-p05417-102926https://curecurrent.com/trials/atacicept-in-combination-with-rituximab-in-subjects-with-rheumatoid-arthritis-august-iii-102927https://curecurrent.com/trials/formation-of-antibodies-and-subsequent-prediction-of-clinical-response-in-patients-with-rheumatoid-arthritis-treated-wit-102928https://curecurrent.com/trials/the-effect-of-bms-986142-on-the-pharmacokinetics-of-a-combined-oral-contraceptive-oc-containing-ethinyl-estradiol-ee-and-102929https://curecurrent.com/trials/antifolate-effectiveness-in-arthritis-102930https://curecurrent.com/trials/long-term-assessment-of-safety-and-physical-function-with-amg-108-in-ra-102931https://curecurrent.com/trials/a-study-on-rheumatoid-arthritis-patients-treated-with-rituximab-102932https://curecurrent.com/trials/efficacy-and-safety-study-of-abp-501-compared-to-adalimumab-in-subjects-with-moderate-to-severe-rheumatoid-arthritis-102933https://curecurrent.com/trials/safety-study-of-abatacept-to-treat-rheumatoid-arthritis-a-102934https://curecurrent.com/trials/high-intensity-interval-training-and-rheumatoid-arthritis-102935https://curecurrent.com/trials/pharmacokinetics-safety-and-tolerability-study-of-single-dose-of-abatacept-125mg-administered-subcutaneously-102936https://curecurrent.com/trials/therapeutic-use-of-tadekinig-alfa-in-adult-onset-still-s-disease-102937https://curecurrent.com/trials/a-dose-range-finding-study-of-jnj-39758979-in-patients-with-active-rheumatoid-arthritis-currently-treated-with-methotrex-102938https://curecurrent.com/trials/phase-ii-study-evaluating-the-safety-and-efficacy-of-gsk315234a-in-patients-with-rheumatoid-arthritis-102939https://curecurrent.com/trials/a-study-of-tocilizumab-in-participants-with-active-rheumatoid-arthritis-ra-and-an-inadequate-response-to-non-biological-102940https://curecurrent.com/trials/curcuma-longa-l-in-rheumatoid-arthritis-102941https://curecurrent.com/trials/a-non-interventional-study-of-roactemra-actemra-tocilizumab-in-patients-with-rheumatoid-arthritis-102942https://curecurrent.com/trials/anti-biopharmaceutical-immunization-prediction-and-analysis-of-clinical-relevance-to-minimize-the-risk-of-immunization-i-102943https://curecurrent.com/trials/a-long-term-extension-study-of-wa22762-to-evaluate-safety-and-efficacy-of-subcutaneous-tocilizumab-in-participants-with-102944https://curecurrent.com/trials/assess-safety-tolerability-pharmacokinetics-and-clinical-activity-of-amp-110-in-subjects-with-rheumatoid-arthritis-102945https://curecurrent.com/trials/occupational-performance-problems-in-individuals-with-rheumatoid-arthritis-102946https://curecurrent.com/trials/observational-study-of-golimumab-intravenous-infusion-102947https://curecurrent.com/trials/pharmacokinetics-and-metabolism-study-of-radiolabeled-bms-986142-in-healthy-male-subjects-102948https://curecurrent.com/trials/effect-of-a-thin-customized-insole-in-ra-102949https://curecurrent.com/trials/good-eular-response-in-patients-with-early-rheumatoid-arthritis-102950https://curecurrent.com/trials/a-study-to-investigate-the-safety-and-efficacy-of-abt-122-given-with-methotrexate-in-subjects-with-active-rheumatoid-art-102951https://curecurrent.com/trials/regulation-of-the-immune-system-in-response-to-the-treatment-with-tocilizumab-in-rheumatoid-arthritis-patients-102952https://curecurrent.com/trials/a-long-term-extension-study-of-wa22763-and-na25220-of-subcutaneous-roactemra-actemra-tocilizumab-in-patients-with-modera-102953https://curecurrent.com/trials/a-long-term-safety-extension-study-of-wa19926-in-participants-with-rheumatoid-arthritis-102954https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-re-treatments-with-rituximab-in-patients-with-active-rheumatoid-arthritis-who-have-102955https://curecurrent.com/trials/a-retrospective-observational-study-on-compliance-in-patients-with-rheumatoid-arthritis-on-treatment-with-roactemra-acte-102956https://curecurrent.com/trials/a-retrospective-chart-review-of-mabthera-rituximab-treatment-in-rheumatoid-arthritis-ra-participants-in-australia-102957https://curecurrent.com/trials/a-study-to-assess-the-safety-and-efficacy-of-tocilizumab-in-patients-with-active-rheumatoid-arthritis-102958https://curecurrent.com/trials/an-observational-study-of-roactemra-actemra-tocilizumab-in-patients-with-rheumatoid-arthritis-treated-with-glucocorticoi-102959https://curecurrent.com/trials/a-retrospective-chart-review-on-the-use-of-biologics-in-monotherapy-for-the-treatment-of-patients-with-rheumatoid-arthri-102960https://curecurrent.com/trials/a-study-of-p38-inhibitor-4-monotherapy-in-patients-with-active-rheumatoid-arthritis-102961https://curecurrent.com/trials/an-observational-study-of-glucocorticoid-use-in-patients-with-rheumatoid-arthritis-on-treatment-with-roactemra-actemra-t-102962https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-mlta3698a-in-combination-with-a-disease-modifying-anti-rheumatic-drug-dma-102963https://curecurrent.com/trials/switch-clinical-trial-for-patients-with-rheumatoid-arthritis-who-have-failed-an-initial-tnf-blocking-drug-102964https://curecurrent.com/trials/a-non-interventional-study-of-roactemra-actemra-tocilizumab-treatment-in-patients-with-rheumatoid-arthritis-102965https://curecurrent.com/trials/an-observational-study-in-rheumatoid-arthritis-patients-treated-with-roactemra-actemra-tocilizumab-102966https://curecurrent.com/trials/an-observational-study-of-roactemra-actemra-tocilizumab-in-smoking-versus-non-smoking-patients-with-rheumatoid-arthritis-102967https://curecurrent.com/trials/observational-safety-study-of-rituximab-in-patients-diagnosed-with-rheumatoid-arthritis-ra-who-did-not-respond-adequatel-102968https://curecurrent.com/trials/a-non-interventional-study-of-roactemra-actemra-tocilizumab-in-monotherapy-in-patients-with-rheumatoid-arthritis-monaco-102969https://curecurrent.com/trials/an-observational-study-on-fatigue-in-patients-with-rheumatoid-arthritis-treated-with-roactemra-actemra-tocilizumab-102970https://curecurrent.com/trials/a-study-of-subcutaneously-administered-tocilizumab-in-patients-with-rheumatoid-arthritis-102971https://curecurrent.com/trials/an-observational-study-of-roactemra-actemra-in-patients-with-moderate-to-severe-rheumatoid-arthritis-102972https://curecurrent.com/trials/a-study-of-the-effect-of-roactemra-actemra-tocilizumab-in-combination-with-methotrexate-on-articular-damage-in-the-hand-102973https://curecurrent.com/trials/an-observational-study-of-dosage-patterns-in-routine-clinical-practice-in-patients-with-rheumatoid-arthritis-act-life-102974https://curecurrent.com/trials/a-study-to-assess-the-effect-of-tocilizumab-dmard-therapy-on-signs-and-symptoms-in-patients-with-moderate-to-severe-acti-102975https://curecurrent.com/trials/an-observational-study-on-patients-with-rheumatoid-arthritis-treated-with-mabthera-rituximab-102976https://curecurrent.com/trials/an-observational-study-of-roactemra-actemra-tocilizumab-in-combination-with-methotrexate-in-patients-with-rheumatoid-art-102977https://curecurrent.com/trials/a-retrospective-observational-study-on-the-use-of-biologics-in-monotherapy-in-patients-with-rheumatoid-arthritis-102978https://curecurrent.com/trials/an-observational-study-of-rituximab-in-combination-with-methotrexate-in-participants-with-active-rheumatoid-arthritis-102979https://curecurrent.com/trials/a-non-interventional-study-in-patients-with-rheumatoid-arthritis-who-are-treated-with-roactemra-actemra-tocilizumab-102980https://curecurrent.com/trials/a-study-of-roactemra-actemra-tocilizumab-in-patients-with-active-rheumatoid-arthritis-who-have-an-inadequate-response-to-102981https://curecurrent.com/trials/an-observational-study-of-roactemra-actemra-tocilizumab-in-rheumatoid-arthritis-patients-102982https://curecurrent.com/trials/a-study-of-mabthera-rituximab-in-patients-with-rheumatoid-arthritis-who-have-had-an-inadequate-response-to-a-single-anti-102983https://curecurrent.com/trials/a-long-term-extension-study-of-roactemra-actemra-tocilizumab-in-patients-with-early-moderate-to-severe-rheumatoid-arthri-102984https://curecurrent.com/trials/an-observational-study-of-mabthera-rituxan-rituximab-in-patients-with-active-rheumatoid-arthritis-who-have-an-inadequate-102985https://curecurrent.com/trials/local-non-interventional-study-of-roactemra-tocilizumab-in-poland-act-pol-first-line-treatment-in-routine-clinical-pract-102986https://curecurrent.com/trials/an-observational-study-on-long-term-effectiveness-and-safety-of-roactemra-actemra-tocilizumab-in-daily-practice-in-patie-102987https://curecurrent.com/trials/a-study-to-assess-the-effect-of-tocilizumab-methotrexate-on-signs-and-symptoms-in-patients-with-moderate-to-severe-activ-102988https://curecurrent.com/trials/a-study-of-p38-inhibitor-4-in-patients-with-active-rheumatoid-arthritis-ra-on-stable-methotrexate-therapy-102989https://curecurrent.com/trials/an-observational-study-of-roactemra-actemra-tocilizumab-in-patients-with-rheumatoid-arthritis-who-have-an-inadequate-res-102990https://curecurrent.com/trials/a-study-assessing-the-safety-and-efficacy-of-subcutaneous-roactemra-actemra-alone-or-in-combination-with-non-biologic-an-102991https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-mabthera-alone-and-in-combination-with-either-cyclophosphamide-or-methotr-102992https://curecurrent.com/trials/a-canadian-study-to-evaluate-early-use-of-adalimumab-after-methotrexate-failure-in-early-rheumatoid-arthritis-102993https://curecurrent.com/trials/safety-and-efficacy-vagal-nerve-stimulation-in-patients-with-rheumatoid-arthritis-102994https://curecurrent.com/trials/a-study-to-investigate-the-use-of-golimumab-simponi-in-participants-with-rheumatoid-arthritis-psoriatic-arthritis-and-an-102995https://curecurrent.com/trials/long-term-extension-study-for-spm-005-participants-102996https://curecurrent.com/trials/99m-technetium-glucosamine-in-arthritis-102997https://curecurrent.com/trials/a-study-of-mavrilimumab-versus-anti-tumor-necrosis-factor-in-subjects-with-rheumatoid-arthritis-102998https://curecurrent.com/trials/a-prospective-observational-study-of-tocilizumab-roactemra-actemra-in-participants-with-rheumatoid-arthritis-102999https://curecurrent.com/trials/mid-term-outcomes-of-first-mtp-arthroplasty-with-primus-fgt-implant-103000https://curecurrent.com/trials/an-observational-study-of-roactemra-actemra-tocilizumab-as-monotherapy-in-rheumatoid-arthritis-patients-in-routine-clini-103001https://curecurrent.com/trials/2-week-dc-of-mtx-and-influenza-vaccination-in-ra-103002https://curecurrent.com/trials/bone-resorption-osteoclastogenesis-and-adalimumab-103003https://curecurrent.com/trials/a-study-of-cnto-136-sirukumab-administered-subcutaneously-in-japanese-patients-with-active-rheumatoid-arthritis-unrespon-103004https://curecurrent.com/trials/the-anti-inflammatory-and-metabolic-effects-of-rosiglitazone-in-subjects-with-rheumatoid-arthritis-103005